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ABSTRACT
The aqueous leaf extract of Rubus suavissimus (Chinese sweet leaf tea) was active in
inhibiting angiogenesis, which could be used to suppress adipogenesis and cause weight loss.
Following this revelation and approach, the anti-obesity effect was thoroughly investigated in
normal and obese rat models.
The investigations began with the preparation of quality-controlled extract. First, the
crude extraction methods were examined leading to the characterization of the chemical
composition. Second, the impure components were removed by alcohol precipitation and column
chromatography, resulting in a standardized sweet leaf tea extract (RUS). Third, three
bioavailable compounds identified from the urine analyses were re-constituted to form the
purified sweet leaf tea extract (GER), which accounted for 27% by weight of the RUS. These
standardized and purified sweet leaf tea extracts were then evaluated for their anti-obesity effect
in normal and obese-prone rats.
Both RUS and GER reduced body weight gain by 7% (p =0.999) in normal rodents but
statistical analyses failed to show any significance due to small sample size. Amazingly, it was
discovered that the use of the tri-compounds combination (GER) produced the same anti-obesity
effect as the standardized extract (RUS). Consequently, new experiments were focused on the
GER using obese-prone rats as the study model. GER showed a significant anti-obesity effect by
reducing 22% (p≤ 0.001) weight gain compared to the high-fat diet control group. Total
abdominal fat was reduced significantly by 48%, indicating that the lost body mass was mainly
due to the loss of body fat. Other benefits of the Chinese sweet leaf tea extract included lowered
blood glucose, cholesterol, and triglycerides. Food intake was not affected. No adverse effects
were observed.

viii

This research provides exciting insights about the novel use of the Chinese sweet leaf tea
as a safe and effective anti-obesity agent beyond its historic use as a natural sweetener. Human
clinical investigations are strongly warranted to determine the effective doses and long-term use
safety in combating obesity or managing body weight.
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CHAPTER 1. INTRODUCTION
Epidemiological and experimental studies have provided convincing evidence that the
consumption of plant-derived foods, such as vegetables, fruits, nuts, spices, and grains, exerts
beneficial effects on human health due to the presence of phytochemicals or non-nutrient
secondary metabolites in them. Crude herbs, for example, have been used as traditional
medicines in different cultural practices to treat or prevent diseases, including cancer (Stoner and
Mukhtar 1995; Pezzuto 1997), metabolic syndrome (Xie et al., 2002; Ekanem et al., 2007;
Lemaure et al., 2007; Modak et al., 2007; Lee et al., 2008; Yin et al., 2008), inflammation (Fang
et al., 2008; Rogerio et al., 2008; Papoutsi et al., 2008), and infectious diseases (Patel et al.,
2004). In the past few years, bioactive components found in plant-derived food, such as
polyphenol and terpenoids, have been commercialized as food or non-food products due to the
increased demand from the health conscious consumers (Espin et al., 2007; Itokawa et al., 2008).
Rubus species (Rosaceae), among the common herbal medicines, have long been used for
therapeutic purposes (Patel et al., 2004). In the screening of plant-sourced angiogenesis
inhibitors, a perennial plant widely distributed in southwestern China, Rubus suavissimus, was
tested positive for antiangiogenic activity and gallic acid (Fig. 1.1) may be partially responsible
for the activity (Liu et al., 2006).
COOH

OH
OH
OH

Figure 1.1. Gallic Acid Structure
Currently, there are 250 species of Rubus established worldwide in the Rosaceae family.
Rubus species have been used traditionally as therapeutics and shown anti-cancer, anti-bacterial,
anti-diabetes, and anti-anemia properties (Patel et al., 2004). R. suavissimus S. Lee is a perennial
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shrub widely abundant in Guangxi and Guizhou provinces of China. The leaf of R. suavissimus
is the material to make beverage leaf tea by the local residents. Due to its intense natural sweet
taste, it is often called tiancha in Chinese, or “Chinese sweet tea” (Liu et al., 2006). The sweet
taste from the sweet leaf is attributed to the presence of diterpene glucosides where the major
sweet principle comes from rubusoside (Patel et al., 2004; Liu et al., 2006). These sweet
diterpene glucosides were limited to the leaves and fruits of R. suavissumus (Chou et al., 1987)
and undetectable in the roots. Instead, triterpene glucosyl esters, such as the suavissimoside F1,
were specifically isolated from the roots of R. suavissimus (Gao et al., 1985). Other diterpene
glucosides contributing to the sweetness and bitterness of the tea leaf include the sweet
glycosides, suavioside A (Hirono et al., 1990), suaviosides B, G, H, I, and J as well as the bitter
glycosides, suaviosides C1, D2, and F (Ohtani et al., 1992). Rubusoside (Fig. 1.2), a sweet
steviol glycoside as well as a dominant diterpene glucoside, is widely used as a natural sweetener
and food additive in the food industry (Tanaka, 1997; Sugimoto et al., 2002) due to its intense
sweetness. The sweetness of rubusoside is said to be about 115 times sweeter than sucrose at a
concentration of 0.025%. However, it has a slightly bitter aftertaste which affects the quality of
rubusoside as a candidate for natural sweetener (Hirono et al., 1990; Patel et al., 2004; Liu et al.,
2006). Therefore, improvements in the sweetness and quality of rubusoside through enzymatic 1,
4-α-transglucosylation were investigated previously and a significant improvement of sweetness
was observed in most di- and tri-glycosylated products (Darise et al., 1984; Kitahata et al., 1989;
Ohtani et al., 1991; Tanaka, 1997).
In addition to the use of Chinese sweet leaf as a natural sweetener, it has been applied as
a folk medicine to treat various diseases. In southern China, the sweet leaf is used as a traditional
remedy to treat hypertension, diabetes, and atherosclerosis, maintaining healthy kidneys, as well
as to relieve cough (Huang and Jiang, 2002). Recent studies have also demonstrated that the
2

Chinese sweet leaf tea extract exhibits anti-inflammatory, anti-allergy (Ishikura et al., 1995;
Kotaro, 1997; Ono, 2004), and anti-angiogenesis activities (Liu et al., 2006). As a potential
natural inhibitor of angiogenesis, sweet leaf tea extract has been reported capable of reducing
corneal neovascularization in experimental rodents (Oner et al., 2007). Moreover, the ability of
sweet leaf extract in inhibiting the transcription factor nuclear factor kappa B or, NF-κB (Liu et
al., 2005) and α-amylase activity (Li et al., 2007), may prevent certain metabolic diseases such
as diabetes and obesity. This may further support the use of the tea leaf as a traditional folk
medicine in treating or regulating glucose metabolism. More recently, a validated chemical
fingerprint analysis was developed, which further provides a reliable quality assessment of the
Chinese sweet leaf tea extract (Chou et al., 2009). In the chemical fingerprint analysis, Chou et
al. (2009) has identified five marker compounds in the leaves of Chinese sweet tea plant, which
include the gallic acid, rutin, ellagic acid, rubusoside, and steviol monoside. With the
development of chemical fingerprint analysis for the Chinese sweet leaf tea extract, qualitative
and quantitative measurements of the extract can be determined more accurately. This could
translate to reduced batch-to-batch variations.
O

R1

O
O
R2

Figure 1.2. Rubusoside Structure: R1 = R2 = Glucose
Since most studies on Chinese sweet leaf tea were currently focused on the chemical
analyses, a validated and thorough study relating to the in vivo studies is scarce. Thus, it brought
up another question whether these bioactive components found in the leaves of R. suavissimus
are orally active and can produce a positive response in live animals. Indeed, to ensure consistent
3

and reliable results from either in vitro or in vivo studies, quality controlled extracts with
promising bioactivity are essential. In the present study, preparation of the extract using different
extraction methods and alcohol precipitation was examined. The prepared and purified extract
was evaluated for its anti-obesity effect. It is hoped that present study would provide a defined
pharmacological effect of the Chinese sweet leaf extract and the effect can be repeated in future
human studies.
The objectives of this study are (1) to compare the novel extraction techniques with the
traditional extraction method in the production of high quality leaf extract, (2) to develop an
efficient and cost effective method in purifying the crude extract of the leaves of R.suavissimus,
(3) to examine the effect of the purification procedure on the changes of chemical composition
between the purified and precipitated leaf extract, (4) to determine the bioactive and bioavailable
chemical compounds in vivo via chemical analyses, and (5) to examine anti-obesity effect of the
Chinese sweet leaf tea extract in normal and high fat diet-induced rats. The information shortage
on the sample preparations and its pharmacological function on body weight changes prompted
the investigation over the Chinese sweet leaf tea extract. Hopefully, with the detailed
investigations, we will be able to reveal the functions of the Chinese sweet leaf tea extract
beyond its historic use as a natural sweetener or beverage leaf tea.

4

CHAPTER 2. EXTRACTION OF BIOACTIVE COMPONENTS IN THE CHINESE
SWEET TEA PLANT (RUBUS SUAVISSIMUS S. LEE) BY DIFFERENT METHODS
2.1 Background
Rubus suavissiumus is a perennial shrub naturally abundant in Southern China. Due to their
intense sweet taste, the leaves of the R. suavissimus (Chinese sweet leaf tea plant) have been
used in making beverage leaf tea by the local residents. Rubusoside, one of the dominant sweet
principles in the Chinese sweet leaf tea plant, is 115 times sweeter than sucrose at a
concentration of 0.025%, making it a good candidate for natural sweetener (Ohtani et al., 1992;
Sugimoto et al., 2002). In addition, the Chinese sweet leaf has also been applied as a folk
medicine to treat various diseases such as hypertension, diabetes, atherosclerosis, to maintain
healthy kidneys and relieve coughs (Huang and Jiang, 2002), as well as to alleviate inflammation
and allergy (Kotaro, 1997; Ono, 2004; Fang et al., 2008). Recently, the aqueous leaf extract of
R. suavissimus was also found to inhibit angiogenesis, partially via gallic acid that was present
(Liu et al., 2006).
While our research focuses on analyzing the water extract of Chinese sweet leaf tea
(Chou et al., 2009) and testing it for bioactivities (Liu et al., 2006; Oner et al., 2007) because of
the historic beverage use, the question centers around whether a sweet-taste-based tea
preparation stands to the bioactivity test and validation. This is because a thorough and validated
study on the preparation of the tea leaf extract using non-traditional methods has not yet been
conducted nor evaluated. We are concerned if the traditional hot water extraction of the Chinese
sweet leaf tea has actually maximized the recovery of desired bioactive components rather than
the sweetening components only. This concern prompted the investigation to determine if the
traditional extraction method oriented for preparing beverage tea is suitable in the preparation of
the functional tea extract characterized by the bioactive compounds. Since the initial crude
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extraction method defines the extractable composition for further purifications using methods
such as alcohol precipitation (Koh et al. 2009), the initial crude extraction method is a crucial but
often ignored step that warrants special examination.
Maceration using food-grade and food-compatible organic solvent and hot water
extraction are the most common extraction methods in the preparation of the traditional herbal
medicines. Chinese sweet leaf tea, for example, is conventionally prepared by the hot water
extraction or the boiling method. Li et al. (2007) reported that these conventional extraction
methods were effective in extracting antioxidant from a wide variety of plants and are applicable
to both food industry and individual consumers at home. During the maceration process, plant
materials are soaked in an organic solvent for certain lengths of time often assisted with agitation
to facilitate the diffusion of metabolites into the solvent. However, maceration requires large
amounts of solvent and lengthy time. Therefore, the simple maceration method, comparing to
other novel extraction techniques such as pressurized liquid extraction (PLE), is labor-intensive
and time-consuming for a complete recovery of desired components. Hot water extraction is
another common method used in tea preparations. Although the hot water extraction takes much
less time, the extracted components through the method often are water soluble (e.g.,
polysaccharides).
In addition to the conventional extraction methods described above, recently developed
new extraction techniques such as PLE can be employed for the initial crude extraction of the
Chinese sweet leaf tea. These new techniques generally have the advantages of reducing the
consumptions of organic solvents, decreasing the risk of sample degradation, and saving time
and labor (Deng et al., 2007). These advantages result in the improvement of overall extraction
efficiency and effectiveness. PLE, initially designed for extracting environmental pollutants
(Benthin et al., 1999; Ong et al., 2004), is becoming a widely used technique in the
6

pharmaceutical and food industries. (Shen and Shao, 2005; Herrero et al., 2006; Jiang et al.,
2006; Li et al., 2006; Peres et al., 2006; Smelcerovic et al., 2006; Chukwumah et al., 2007; Jiang
et al., 2007).
PLE uses organic solvent at elevated temperatures up to 200ºC and relatively high
pressure between 4 and 20 MPa (Ong et al., 2004; Deng et al., 2007). With the elevated
temperature and pressure, the viscosity and surface tension of the solvent are decreased, and
thereby accelerate the solubility and diffusion rate of compounds (Huie, 2002; Deng et al., 2007).
Studies on medicinal plants (Waksmundzka-Hajnos et al., 2004; Li et al., 2006; Jiang et al.,
2006; Peres et al., 2006; Jiang et al., 2007) demonstrated the advantages of PLE in reducing the
solvent volume and extraction time. Under an optimized condition, only one extraction cycle was
needed to recover most active constituents in plants (Jiang et al., 2006; Li et al., 2006) whereas
soxhlet and sonication often require multiple extraction cycles.
The current study was to investigate the effects of alternative solvent and new extraction
apparatus on the extraction of Chinese sweet leaf tea using the traditional hot water extraction as
the control. These effects were evaluated through the qualitative and quantitative analyses of
various resulting crude extracts on high performance liquid chromatography (HPLC). Five
marker components, gallic acid, rutin, ellagic acid, rubusoside, and steviol monoside were
quantified. Experiments were designed to test the hypothesis that the traditional hot water
extraction method is not sufficient to extract these five functional compounds.
2.2 Materials and Methods
2.2.1 Plant Materials
Air-dried leaves of the Chinese sweet leaf tea plant (Rubus suavissimus S. Lee)
(Batch#SLT20070206) were provided by Guangxi Normal University in Guilin, China.
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2.2.2 Sample Preparations
2.2.2.1 Hot Water Extraction (HW)
Dried and ground leaves were weighed into an Erlenmeyer flask and soaked for an hour in
deionized and distilled water at a ratio of 1:15 w/v. The water solution was brought to boil for 60
min. Then, the solution was filtered with a filter paper (Whatman #4) to separate the solid from
the liquid. The solid residuals were rinsed with half of the initial solvent volume, filtered, and
combined with the first extraction. The combined solutions were later concentrated and freezedried to a powdered extract and the extraction yield was obtained (% w/w). This procedure was
done in three replications.
2.2.2.2 Maceration (MA)
Dried and ground leaves were weighed into an Erlenmeyer flask and extracted at a leaf to solvent
ratio of 1:15 w/v with aqueous ethanol of 0%, 20%, 50%, 70%, or 95%, respectively. To perform
the extractions, the samples were mixed and sealed well with parafilm to avoid contamination
and to minimize solvent evaporation. Then, the samples were placed on an orbital shaker at 80
rpm for 72 hours. After 72 hours, the extract solutions were separated from the solids through
filtration with filter papers (Whatman #4) and the solid residuals were rinsed with half of the
initial solvent volume. Supernatant solutions were later combined, condensed, and freeze-dried
to obtain the powdered extracts and extraction yield (% w/w). Dried extracts were stored in
room temperature until HPLC analyses. Each treatment was done in three replications.
2.2.2.3 Low-pressurized Liquid Extraction (LP)
The low-pressurized liquid extraction was performed with an extractor (TECNOLAB, Via Vitale
Rosi, Spello, Italy) equipped with a 2-L extraction cell. Dried and ground leaves were weighed
into the extraction cell and extracted with aqueous ethanol of 0%, 20%, 50%, 70%, or 95% at a
leaf to solvent ratio of 1:15 w/v, respectively. Extraction was conducted at 85 psi (5.86 bars) for
8

60 min (6 extraction cycles with 8 min of compression and 2 min of decompression) at 20°C.
Extract solutions were discharged and residuals were rinsed with half of the initial solvent
volume. The initial and rinsed liquids were combined, filtered with filter paper (Whatman # 4),
and then freeze-dried to obtain powdered extracts and extraction yield (% w/w). Dry extracts
were stored in room temperature until HPLC analyses. The procedure was done in three
replications.
2.2.2.4 High-pressurized Liquid Extraction (HP)
The high-pressurized liquid extraction (ASE 150, Dionex, Bannockbum, IL) was conducted
under the pressure of 1500 psi (103 bars) and temperature at 80°C. Under these conditions, the
leaf samples were extracted for 30 min (15 min per cycle) using 0%, 20%, 50%, 70%, or 95%
aqueous ethanol, respectively. After the extraction, the samples were rinsed with an equal
volume of initial solvent and purged for 100 seconds. All extractions were done with a 34-ml
extraction cell containing 5 g of leaf material each at a leaf to solvent ratio of approximately 1:15
w/v. Extraction and rinse solutions were collected and combined, then evaporated and freezedried to obtain powdered extracts and extraction yield (% w/w). Dry extracts were stored in room
temperature until HPLC analyses. The procedure was done in three replications.
2.2.3 HPLC Analysis
2.2.3.1 Reference Standards
Gallic acid (GA; Purity > 98%), rutin (RUT; Purity > 95%), and ellagic acid (EGA; Purity >
95%) were purchased from Sigma Chemical Company (St. Louis, MO). The reference standards
of rubusoside (RUB) and steviol monoside (STM) were isolated by our own lab and identified by
spectral data (UV, MS, 1H NMR, 13C NMR and 2D-NMR). Both RUB and SM have purities
greater than 98% by HPLC–PDA analyses based on a peak-area normalization method.
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2.2.3.2 HPLC Conditions
An HPLC system consisting of a Waters (Milford, MA) 600 pump, a 717 auto-sampler, and a
UV/Vis Photodiode Array (PDA) 2996 Detector were used for all analyses. Chromatographic
separations were run on an Alltech Prevail C18 column (250 mm × 4.6 mm, 5 µm) with a C18
Guard column (7.5 mm×4.6 mm, 5 µm). The mobile phase was consisted of solvent A (0.17%
phosphoric acid in acetonitrile) and solvent B (0.17% phosphoric acid in water). The elution
profile for A is: 0–65 min, linear gradient of 5-30%; 65–85 min, linear gradient of 30–60%; 85–
90 min, linear gradient of 60–70%; and 90–100 min, isocratic 70%. A pre-equilibration period of
20 min was used between individual runs. Column temperature was maintained at 25°C. The
flow rate wass 1.0 mL/min and the injection volume was 10 µL. All compounds were detected at
dual wavelengths of 254 and 205 nm to derive at combined chromatograms.
2.2.4 Similarity Analysis
A similarity test among the 16 samples resulted from HW (control) and 15 treatment
combinations consisting of three extraction methods and five solvent systems was performed
using the software named Similarity Evaluation System for Chromatographic Fingerprint of
Traditional Chinese Medicine (2004A). The matching of the fingerprints of each sample was
done by a multipoint calibration mode based on retention time and UV spectra. With the test, a
reference chromatogram was generated from the samples as a standard fingerprint. Then, the
similarity of each chromatogram against this reference chromatogram was calculated.
2.2.5 Statistical Analysis
Data were analyzed using the analysis of variance (ANOVA) procedure of Statistical Analysis
System (SAS, Cary, NC). The effects of solvent systems (SOLVENT) and extraction methods
(METHOD) on the yield of five marker compounds were analyzed. Two-way factorial
arrangements were examined at 3 (extraction methods with MA, LP, and HP) and 5 levels
10

(aqueous ethanol concentrations at 0, 20%, 50%, 70%, and 95%), respectively. Tukey’s post hoc
test was performed to compare the means of the main effects as well as their interactions.
Significance of all tests was set at p ≤ 0.05 and all results reported were expressed as mean ±
SEM unless otherwise specified.
2.3 Results
2.3.1 Effects of the Extraction Methods and Solvent Systems on the Yields of Marker
Compounds in the Chinese Sweet Leaf Tea Extract
Compared to the commonly used hot water extraction (HW), the LP method extracted
significantly less components regardless of the solvent systems used (Fig. 2.1). Similarly, the
extraction yield (the extractable solids) was the lowest at the 95% solvent system regardless of
the extraction method used. Under the above conditions, the hot water extraction was superior in
term of extraction yield. Except at the 95% solvent system, the HP and MA methods in
combination of all solvent systems resulted in either equal or better extraction yield than the hot
water extraction method. In fact, the highest extraction yield (about 35% w/w) was attained by
the HP method when combined with the 20% to 70% aqueous ethanol, superior to the hot water
extraction method with a yield of 28.6% w/w.
To further examine the effect of the extraction methods and solvent systems as well as
their interaction on each of the marker compound, a two-way factorial arrangement was
conducted. Results showed that the main effects, extraction methods and ethanol concentrations,
as well as their interactions had significant influences on the concentrations of all markers
compounds (Table 2.1).
In the extracts obtained using various combinations of extraction methods and solvent
systems, the effects on the concentrations of each marker compound varied. The MA method
extracted significantly more gallic acid than the HW method, especially when extracted with
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20% ethanol, to a concentration of 0.26% w/w, which is almost 5-fold more than that extracted
with the HW method (Fig. 2.2). Most of the other extraction methods or solvent systems
extracted about the same amount of gallic acid as the commonly used hot water extraction,
although some combinations did either slightly better or poorer.
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Figure 2.1. Effect of ethanol concentrations on the total yield (% w/w) of the Chinese sweet leaf
tea (Rubus suavissimus) extract prepared by the maceration (MA), low-pressurized (LP), and
high-pressurized (HP) liquid extraction methods. The commonly used hot water extraction (HW)
is used as reference shown in a dash line. Different letters indicate a significant difference in the
extraction yields among the extraction methods at the particular ethanol concentration. Values
are expressed as mean ± standard deviation (vertical line; n=3).

Unlike gallic acid, the concentrations of rutin, ellagic acid, rubusoside, and steviol
monoside extracted by the MA, LP and HP methods increased with the ethanol concentrations in
a non-linear fashion and reached their maximum yields at 70% or higher (Fig. 2.2). Interestingly,
the concentrations of these compounds extracted by the MA, HP, or LP were not affected by the
solvent systems ranging from 20% EtOH to 70% EtOH. The LP method, however, behaved
differently from the MA or HP method. Instead of increases, the 95% aqueous ethanol system
caused rapid decreases of rutin, ellagic acid, rubusoside, and steviol monoside by 22%, 12.5%,
11% and 8% with LP method, respectively, from their peak values seen at the 70% EtOH.
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Table 2.1. Statistical results of the main effects, Method and Solvent, as well as their interactions
(Method*Solvent) on the concentrations of the five marker compounds, gallic acid (GA), rutin
(RUT), ellagic acid (EGA), rubusoside (RUB), and steviol monoside (STM).
Compounds
GA
Method
Solvent
Method*Solvent

Num DF

Den DF

F-Value

Pr > F

2
4
8

30
30
30

373.18
364.34
121.27

<.0001
<.0001
<.0001

RUT
Method
Solvent
Method*Solvent

2
4
8

30
30
30

12.25
101.29
3.59

0.0001
<.0001
0.0049

EGA
Method
Solvent
Method*Solvent

2
4
8

30
30
30

106.65
473.09
18.77

<.0001
<.0001
<.0001

RUB
Method
Solvent
Method*Solvent

2
4
8

30
30
30

79.60
889.00
41.39

<.0001
<.0001
<.0001

STM
Method
Solvent
Method*Solvent

2
4
8

30
30
30

132.44
1354.23
27.95

<.0001
<.0001
<.0001

Regardless of any method used, the organic solvent systems were superior to the HW
method in extracting rutin, ellagic acid, and steviol monoside. Steviol monoside, indeed,
appeared to be non-extractable with the HW or other methods using water. However, a different
phenomenon was observed in the extraction of rubusoside. Fig. 2.2 showed that the
concentration of rubusoside prepared by the HW method was almost 3-fold higher (17.9% w/w)
than other water extraction methods (i.e. MA, LP, or HP) and it was not significantly different
from those extracted with 20% to 70% aqueous ethanol using the MA, LP, or HP method. Still,
the highest concentration of rubusoside (24% w/w) was achieved with the MA or HP method in
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combination with the 95% solvent system (Fig. 2.2), which was approximately 25% higher than
that extracted by the HW method.
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Figure 2.2. Effect of ethanol regimens on the concentration (% w/w) of the five marker
compounds in the Chinese sweet leaf tea extract (Rubus suavissimus) prepared by the maceration
(MA), low-pressurized (LP) and high-pressurized (HP) liquid extractions. Hot water extraction
(HW) is used as a reference shown in a dash line. Different letters indicate a significant
difference in the yield of compounds among the extraction methods at the particular ethanol
concentration. Values are expressed as mean ± standard deviation (vertical line; n=3).
2.3.2 Chromatographic Fingerprint Analysis of the Extracts
Overall, the MA and HP methods extracted higher amount and diverse species of chemical
components. To best illustrate this statement, the chemical compositions of their extracts were
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visualized in chromatographic fingerprints focusing on not only the five marker compounds but
also other unknown components that possess characteristic UV absorption peaks (e.g., Peaks 1-8
in Fig. 2.3).
The UV absorption profiles showed more abundant peaks in the extract prepared by the
HP than those by the MA method. Gallic acid showed the highest peak area at 20% EtOH, while
other maker compounds maximized at 95% EtOH. Among the unknown components, Peak 1
appeared to be a single component, with a retention time of approximately 12 minute, displayed
its highest absorption peak area at lower ethanol solvent systems (i.e., 20% and 50% EtOH). In
the 95% EtOH system, peak 1 decreased significantly. This phenomenon was similar in either
MA or HP method. Peak 2 to peak 7, however, spiked at either 70% or 95% EtOH. Indeed, peak
8 appeared to have lower absorption area in the extract prepared by the HP than that by the MA
method. In the comparison of all known and unknown compounds, obviously, water extracts
have less number of peaks and lower degrees of chromatographic absorption profiles than the
extracts prepared by aqueous ethanol.
2.3.3 Similarity Analysis among Extracts
In order to access the similarities of extracts resulted from the HW method and other 3 × 5
treatment combinations, chromatograms resulted from each treatment were compared against a
standard chromatogram using a software (Similarity Evaluation System for Chromatographic
Fingerprint of Traditional Chinese Medicine (2004A)). Generally, the closer the similarity
value, the more similar the samples are. In the study, the similarities of the samples against the
reference chromatogram ranged from 0.276 (least similar) to 0.729 (most similar) (Table 2.2). In
the comparison of HP and MA methods across the five solvent levels, the extracts’ similarities
reached 98% with the 95% EtOH treatment and only 53% with 20% EtOH, in agreements with
the HPLC analyses based on the known five compounds. For the extracts prepared by the LP
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method, however, the similarities ranged from 88.7% (70% EtOH) to 98.1% (20% EtOH) when
compared to the MA method. More interestingly, the similarities of extracts prepared by MA,
LP, and HP method with 95% EtOH were 98.4%, 94.56%, and 99.9%, respectively, when
compared to the extract prepared by the HW method. It is therefore to conclude that the solvent
system, not the extraction methods, was a dominant factor influencing the similarities of the
extract, based on all UV-detected components (known and unknown).
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Figure 2.3. Chromatographic fingerprint of the Chinese sweet leaf tea (Rubus suavissimus)
extracts prepared by maceration (MA) and high-pressurized liquid extraction (HP). Selected
chromatograms demonstrated the extractions using the aqueous ethanol at 0% (0), 20% (20),
50% (50), 70% (70), and 95% (95). Presence of the five marker compounds is indicated as gallic
acid (GA), rutin (RUT), ellagic acid (EGA), rubusoside (RUB), and steviol monoside (STM).
Peak 1-8 are unknown compounds. NOTE: Alignment may be slightly off for some fingerprints
due to graphic demonstration purpose.
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Table 2.2. Similarity analyses among the 16 Chinese sweet leaf tea extracts prepared by hot
water (HW), maceration (MA), low-pressurized liquid extractor (LP), and high-pressurized
liquid extractor (HP), using either water (0), 20% (20), 50% (50), 70% (70), or 95% (95)
aqueous ethanol over a reference chromatogram.
Sample
HW-0
MA-0
MA-20
MA-50
MA-70
MA-95

Similarity
0.717
0.654
0.525
0.664
0.683
0.729

Sample
LP-0
LP-20
LP-50
LP-70
LP-95

Similarity
0.677
0.535
0.577
0.606
0.678

Sample
HP-0
HP-20
HP-50
HP-70
HP-95

Similarity
0.600
0.276
0.643
0.725
0.716

2.4 Discussion
Recent pharmacological studies on the extract of the Chinese sweet leaf tea have revealed
significant health benefits and bioactivities due to the presence of phytochemicals in the plant
extract (Ishikura et al., 1995; Kotaro, 1997; Ono, 2004) especially gallic acid (Liu et al., 2006)
and rubusoside. It is predicted that the overall observed bioactivity of a prepared extract may be
a concerted effort of more than one single component (Liu et al., 2006; 2009 unpublished data).
Although traditionally the quality of the extract was determined on the basis of sweetness, the
extract is now measured for the presence of other bioactive components due to the multiple
bioactivities reported recently. For example, gallic acid is one of the active compounds with
potent anti-angiogenic (Liu et al., 2006) and alpha-glucosidase inhibitory (Li et al., 2007)
activities. Ellagic acid, as a strong antioxidant (Devipriya et al., 2007), possesses the properties
of anti-cancer (Bell and Hawthorne, 2008; Zhang et al., 2008), anti-inflammatory (Papoutsi et
al., 2008), and α-amylase inhibition (Li et al., 2007). Rutin has strong antioxidant (Kartika et al.,
2007; Vukics et al., 2008) and anti-inflammatory activities (Rogerio et al., 2008). Although
scientific research on rubusoside was mostly focused on the development of natural sweetener
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(Tanaka, 1997; Sugimoto et al., 2002), preliminary data has supported that rubusoside may be
potent in the inhibition of bacterial activities (unpublished data).
Liu et al. (2006) showed that the crude water extract of the Chinese sweet leaf tea had
potent anti-angiogenesis activity, which was partially exerted by the presence of gallic acid.
Clearly, a higher level of gallic acid is desirable in the Chinese sweet leaf tea extract. However,
the overall anti-angiogenic activity was not explained by gallic acid alone, which strongly
suggesting the needs of inclusion of other yet-to-be determined compounds. To closely monitor
the changes of each chemical component at different levels of extraction conditions, detailed
fingerprint analyses on the Chinese sweet leaf tea extract were developed (Chou et al., 2009). In
addition to the five marker compounds, it is also imperative to retain other unknown components
until proven not useful to avoid the loss of bioactivity. For example, peak 1 demonstrated a
significant behavior when extracted with 95% EtOH (Fig. 2.3) suggesting its affinity to water
than the ethanol. Peak 8, on the other hand, was extracted more sufficiently with the MA than the
HP method (Fig. 2.3).
In addition to a valid HPLC method, sample preparation is the most critical procedure in
recovering majority of the bioactive compounds, if not all, prior to further purification or
bioactivity screening. Hot water extraction is a commonly applied method in making the
beverage leaf tea and thus it was chosen as a reference method in the present study. Although our
comparisons basically confirmed the validity of it in extracting the sweetening agent rubusoside
and is economical from the solvent point of view, the hot water extraction method has some
typical disadvantages. For example, the method requires a large volume of solvent (water) and
extracts more unwanted water-soluble components such as carbohydrates thus contributes to a
higher impurity of the extract. To optimize the extraction efficiency with purer extracts,
extraction with the use of organic solvents through maceration and pressurized-liquid extractions
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were proven viable in this study. In our study, aqueous ethanol was selected as the extraction
solvent to recover some poorly water-soluble components in addition to the water-soluble
components (Liu 2008). For the known compounds, the water solubility of gallic acid is 11
mg/mL, rutin and ellagic acid are nearly water-insoluble, steviol monoside is about 20 mg/mL,
but rubusoside dissolves equally well in either water or ethanol. Therefore, the use of organic
solvents is likely to increase the extraction efficiency of poor to water-insoluble components.
Our results confirmed that this was the case with the sweet leaf tea. Gallic acid in a 20% ethanol
dissolved more than that in hot water. In every other occasions, 95% ethanol dissolved rutin,
ellagic acid, and steviol monoside significantly more than hot water. These results further
confirmed that the bioactive components, such as gallic acid and ellagic acid, found in the sweet
leaf tea extract, have better solubility in aqueous ethanol than in water. In the study of eight
major classes of legumes, Xu and Chang (2007) reported that antioxidant activity of these
legumes reached an optimum level when extracted with 70% aqueous ethanol. Our findings are
in agreements with others where the aqueous ethanol, as compared to water, had stronger
capability in extracting desired marker compounds.
In addition to the solvent system, the chemical compositions in an extract were highly
dependent on the extraction conditions. Our results showed that gallic acid was highly sensitive
to the temperature and pressure resulted from HP. The yield of rubusoside, on the other hand,
was elevated in the hot water extraction method. Ellagic acid, rutin, and steviol monoside, were
extracted maximally with 95% EtOH using either MA or HP method. HP has been reported to
increase the extraction efficiency of botanical plants (Huei, 2002; Deng et al., 2007) by reducing
the use of solvent volume and labor intensiveness. Our study further confirmed the increased
efficiency of HP in extracting the major components in the Chinese sweet leaf tea. However, the
decreased gallic acid level in the HP extract compared to the MA extract was a major drawback
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for this method. Despite the yield of gallic acid, HP in combination with 95% ethanol was
superior to the HW method in extracting all other marker compounds and the yields were
comparable to the MA method.
The present study found that not a single extraction procedure could extract all marker
components to respective maximum levels. Liu (2008) reported that the combination of extracts
from several sequential extractions may be necessary in recovering majority of the components
in botanical raw material for further bioactivity screening due to the diverse chemical properties
of the bioactive components present in the plant. Therefore, to maximize the levels of all five
major marker compounds in the extraction of Chinese sweet leaf tea, a sequential extraction may
be useful. For instance, to obtain an extract that contains maximal levels of all five compounds, a
sequential extraction method must consist of the extraction of raw material first with the 20%
ethanol via MA to recover gallic acid, then with 95% ethanol to recover other compounds, using
either the MA or HP method, from the same raw materials. However, to maximally extract the
rubusoside from the raw material, HW method would be sufficient considering the unnecessary
use of ethanol. As the sample preparation prompted the result consistency over further biological
studies, an effective and efficient extraction method with standard protocol is warranted to
reproduce the extract with elevated bioactivity level.
2.5 Summary
This is the first study evaluating the crude extraction of the Chinese sweet leaf tea using different
extraction methods and extraction solvent systems. Based on the sweetness of the extract, the
HW method was satisfactory in producing significantly higher amount of rubusoside. However,
if the extraction aims to maximally extract bioactive components, organic solvent systems will
have to be used. To maximally extract all five marker compounds, a sequential extraction
procedure can be used to accomplish this goal.
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CHAPTER 3. PURIFICATION OF A WATER EXTRACT OF CHINESE SWEET TEA
PLANT (RUBUS SUAVISSIMUS S. LEE) BY ALCOHOL PRECIPITATION*
3.1 Background
Rubus suavissimus S. Lee (Rosaceae) is a perennial shrub widely abundant in Guangxi and
Guizhou province of China. The leaf of R. suavissimus is the material to make beverage leaf tea
by the local residents. Due to its intensely sweet flavor, it is better known as “tiancha” in
Chinese, or “Chinese sweet tea”. The sweet taste from the leaf is attributed to the presence of
diterpene glucosides, dominated by the major sweet principle rubusoside (Tanaka et al., 1981).
Rubusoside has a slightly bitter aftertaste, but it is about 115 times sweeter than sucrose at a
concentration of 0.025%, making it a good candidate for a natural sweetener (Ohtani et al., 1992;
Sugimoto et al., 2002). Other diterpene glucosides contributing to the sweetness and bitterness
of the leaf include the sweet glycosides, suavioside A (Hirono et al., 1990), suaviosides B, G, H,
I, and J, as well as the bitter glycoside, suaviosides C1, D2, and F (Sugimoto et al., 2002).
In addition to the use of rubusoside as a natural sweetener, Chinese sweet leaf has also
been used as a folk medicine to treat various diseases. For example, in southern China, it is used
as a traditional remedy for alleviating hypertension, diabetes, atherosclerosis, and maintaining
healthy kidneys as well as to relieve coughs (Huang and Jiang 2002). Recent studies have also
demonstrated that sweet leaf exhibits anti-inflammatory, anti-allergic (Ono, 2004; Kotaro et al.,
1997), and anti-angiogenic activities (Liu et al., 2006). As a potential natural inhibitor of
angiogenesis, sweet leaf tea extract has been reported to be capable of reducing corneal
neovascularization in experimental rodents (Oner et al., 2007). Furthermore, the ability of sweet
leaf to inhibit the transcription factor NF-κB (Liu et al., 2005) and α-amylase activity (Li et al.,
2007) may also prevent certain metabolic diseases such as diabetes and obesity.
*

Reprinted by permission of the Journal of Agricultural and Food Chemistry

21

Traditionally, the sweet leaf as beverage or folk medicine was prepared using boiling
water or decoction. This preparation recovered bioactive compounds such as gallic acid, rutin,
ellagic acid, rubusoside, and steviol monoside as well as other yet-to-be identified compounds
(unpublished data) in a water extract of the sweet leaf. These bioactive compounds may play an
important role in the development of pharmaceutical and food products. For instance, gallic acid
is one of the active compounds that has potent anti-angiogenic (Liu et al., 2006) and alphaglucosidase inhibitory (Li et al., 2007) activities. Ellagic acid and rutin, on the other hand, are
strong antioxidants (Kartika et al., 2007; Vukics et al., 2008), and both compounds may also be
responsible for anti-inflammatory activities (Papoutsi et al., 2008; Rogerio et al., 2008). In
addition, ellagic acid also possesses potent α-amylase inhibitory (Li et al., 2007) and anti-cancer
(Bell and Hawthorne, 2008; Zhang et al., 2008) properties. Although this preparation method
may have extracted the majority of the bioactive components from the leaf material, it also pulls
out a large amount of water-soluble polysaccharides and possibly other macromolecules such as
proteins that are not bioactive, resulting in a crude leaf extract that has room for additional
purification.
A purified extract with potentially improved bioactivity is highly desirable in many ways,
including but not limited to reaching an effective dose range in a practical dosage. The first line
of purification is often associated with the removal of polysaccharides that are not bioactive yet
are highly extractable by boiling water. Alcohol precipitation is often used to achieve this initial
purification of an aqueous extract. This alcohol precipitation method is simple, rapid, easily
scalable, and cost effective in the removal of polysaccharides. Conventional applications of
alcohol precipitation methods are mainly seen during the purification of plant DNA and RNA
(Wang et al., 2004; Gemini et al., 2007) as well as isolation of biologically active
polysaccharides (Schmourlo et al., 2005; Wu et al., 2007; Yang et al., 2008). However,
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employing alcohol precipitation to purify active components from plant extracts is less common.
Alcohol precipitation of crude plant extracts could separate macromolecules and polymers from
small molecules including those of 1000 Daltons or less such as gallic acid, ellagic acid, rutin,
and rubusoside. Therefore, it is hypothesized that during the precipitation process, most of the
polymers, such as polysaccharides and proteins, will precipitate while the small molecules will
stay in the supernatant solution. In the present study, this hypothesis was tested through a series
of experiments and quantitative analyses. Qualitative and quantitative analyses of the purified
extracts were performed using high performance liquid chromatography (HPLC) with the focus
on the five bioactive components as adopted from Chou et al. (2009). Total polysaccharide in the
precipitated extracts was measured by the phenol-sulfuric acid colorimetric method. It is hoped
that this simple but effective method could be demonstrated for the sweet leaf tea extract and
used to achieve satisfactory degrees of purification of many other bioactive botanical extracts.
3.2 Materials and Methods
3.2.1 The Sweet Leaf Material
The sweet leaf tea plants (Rubus suavissimus S. Lee; Rosaceae) used in this study grew on a farm
in Guizhou province, China. A voucher specimen was obtained and deposited in the Herbarium
of the Louisiana State University. Fresh sweet leaves from the sweet leaf tea plants were
harvested in June and air-dried.
3.2.2 Preparation of the Crude Extract
The crude extract was prepared by the industry. The air-dried leaves were extracted with distilled
water at approximately 1:15 w/v ratio. After soaking for 1 h, the decoction was brought to boil
for 60 min. The liquid extract was separated from the solids by filtration with an approximately
100-µm filter screen and cloth, and by still precipitation. In the industry operation, filtration and
still gravity centrifugation were more cost effective than other separation methods such as
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centrifugation. Thus, the particular procedure was chosen in the preparation of crude extract.
Later, the filtered supernatant liquid extract was concentrated and subsequently spray-dried to
powder and designated as the crude extract RUS (batch RUS20040306).
3.2.3 Alcohol Precipitation (AP)
The crude extract (RUS) prepared above was converted to aqueous solutions first by reconstituting the extract in deionized water at 1:4 w/v ratio, with the assistance of heat and stirring
as needed. This aqueous solution was also used as a control regimen expressed as 0% AP (AP-0)
subjected to no alcohol precipitation. For other regimens, appropriate volumes of ethanol (EtOH)
were then added to the water extracts to achieve final ethanol concentrations of 10% (RUS-10),
20% (RUS-20), 30% (RUS-30), 40% (RUS-40), 50% (RUS-50), 60% (RUS-60), 70% (RUS-70),
80% (RUS-80), 90% (RUS-90), and 95% (RUS-95), respectively. These AP solutions were
sealed with parafilm to avoid contaminations and minimize evaporation. Then, the solution was
let stand for an hour at 4°C. Supernatant and precipitant were separated through centrifugation.
The supernatant was removed and the precipitant was rinsed five times, each time with
approximately 20 mL of appropriate ethanol regimens. Supernatant solutions were combined and
filtered with filter papers (Whatman#4) (Whatman, Maidstone, Kent ME14 2LE, UK), then
concentrated to remove ethanol, and freeze-drying to powder. The precipitants, on the other
hand, were subjected to freeze-dry to yield powdered samples. Dry weights of supernatant and
precipitant samples from each regimen were obtained and the yield (% w/w) was calculated
respectively. Each regimen was done in five replicates.
3.2.4 Measurement of Polysaccharide in the Precipitants
3.2.4.1 Development of a Standard Curve
The phenol-sulfuric colorimetric method was a modified method adapted from Gao et al. (2004),
and glucose was used as a standard in the determination of total polysaccharides (PSAC) in the
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precipitant samples. A glucose stock solution was prepared at a concentration of 0.04 mg/mL.
Subsequently, 0.2 mL, 0.4 mL, 0.6 mL, 0.8 mL, 1.0 mL, 1.2 mL, 1.4 mL, or 1.6 mL of the
glucose stock solution was transferred to a test tube and brought up to 2 mL with deionized
water, respectively. A blank solution was prepared with 2 mL of deionized water without
glucose. These preparations resulted in a range of glucose concentrations from 0.008 mg/mL to
0.064 mg/mL. Then, 0.5 mL of 6% phenol solution (Sigma-Aldrich, St. Louis, MO) was added
into each test tube, followed by addition of 5.5 mL of 98% sulfuric acid. Each tube was mixed
well and placed at room temperature for 30 minutes. The optimum absorbance of the reacted
solution was measured at 490 nm using the Ultraviolet (UV)-Visible Spectrophotometer
(Beckman DU 720, Fullerton, CA). A standard curve was obtained by three replications.
3.2.4.2 Precipitant Sample Purification
For the purification process, 20 mg of precipitant sample was dissolved in absolute EtOH at a
ratio of 1:20 w/v. The solution was sonicated for 30 min and centrifuged at 2060 × g for 10 min.
The supernatant was discarded and the precipitant (containing polysaccharides) was dried. The
dried precipitant was then dissolved in a 25-mL volumetric flask with deionized water. The
solution was centrifuged to remove excessive insoluble residue, if any. This was the sample
stock solution.
3.2.4.3 Determination of the Glucose-Equivalent Polysaccharide Content
Pipetted 0.1 mL of the sample stock solution prepared above into a test tube and brought up to 2
mL using deionized water. A blank solution was prepared with 2 mL of deionized water without
sample stock solution. Then, 0.5 mL of 6% phenol solution was added into each test tube
followed by the addition of 5.5 mL of 98% sulfuric acid. Each tube was mixed well and placed at
room temperature for 30 min. The absorbance of reacted solution was measured at 490 nm using
the UV-Visible Spectrophotometer. Glucose concentration and amount were obtained based on
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the standard curve. Polysaccharides content was expressed as glucose-equivalent polysaccharide
in percentage.
3.2.4.4 Recovery Rate
Dissolve 10 mg of a precipitant sample with a known amount of glucose-equivalent
polysaccharide in deionized water at a ratio of 1: 20 w/v. Then, 0.1 mL of the above solution was
pipetted into a test tube followed by an addition of glucose in the amount equivalent to that
found in the respective precipitant sample. The solution was then brought to 2 mL with deionized
water and 0.5 mL of 6% phenol was added into each test tube followed by an addition of 5.5 mL
of 98% sulfuric acid. The contents of each tube were mixed well and placed at room temperature
for 30 min. The absorbance of reacted solution was measured at 490 nm using the UV-Visible
Spectrophotometer. Recovery rate was calculated based on the following formula with five
replications:
Recovery rate (%): [(Total Polysaccharides (mg) – Known Polysaccharides (mg) from
precipitant sample) / Added Glucose (mg)] x 100
3.2.5 HPLC Analysis of the Purified Supernatant Sample
3.2.5.1 Reference Standards
Gallic acid (GA; Purity > 98%), rutin (RUT; Purity > 95%), and ellagic acid (EGA; Purity >
95%) were purchased from Sigma Chemical Company (St. Louis, MO). The reference standards
of rubusoside (RUB) and steviol monoside (STM) were isolated by our own lab and identified by
spectral data (UV, MS, 1H NMR, 13C NMR and 2D-NMR). Both RUB and SM have purities
greater than 98% by HPLC–PDA analyses based on a peak-area normalization method.
3.2.5.2 HPLC Condition
An HPLC system consisting of a Waters (Milford, MA) 600 pump, a 717 auto-sampler, and a
UV/Vis Photodiode Array (PDA) 2996 Detector was used for all analyses. Chromatographic
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separations were carried out on an Alltech Prevail C18 column (250 mm × 4.6 mm, 5 µm) with a
C18 Guard column (7.5 mm×4.6 mm, 5 µm). The mobile phase consisted of solvent A (0.17%
phosphoric acid in acetonitrile) and solvent B (0.17% phosphoric acid in water). The elution
profile for A was: 0–65 min, linear gradient of 5-30%; 65–85 min, linear gradient of 30–60%;
85–90 min, linear gradient of 60–70%; and 90–100 min, isocratic 70%. A pre-equilibration
period of 20 min was used between individual runs. Column temperature was set at 25°C. The
flow rate was 1.0 mL/min and the injection volume was 10 µL. All compounds were detected at
dual wavelengths of 254 (for GA, RUT, and EGA) and 205 (for RUB and STM) to derive
combined chromatograms.
3.2.6 Statistical Analysis
Data were analyzed with Statistical Analysis System (SAS, Cary, NC). Regression analysis was
performed to examine the correlation between the response yield and AP regimen. Statistical
significance of all tests was set at P ≤ 0.05.
3.3 Results
3.3.1 Aqueous Sample Preparations Prior to Alcohol Precipitation
Prior to performing alcohol precipitation of the aqueous extract samples, various extract-to-water
ratios ranging from 1:4 w/v to 1:8 w/v were tested to determine the amount of precipitant (thus
the reciprocal amount of the purified extract) caused by extract solubility itself. It was found that
at the ratio of 1:4 w/v (i.e., 250 mg/ml), approximately 11% of the extract had already
precipitated in water prior to the addition of alcohol. The yield of precipitant showed a constant
rate of insignificant decrease of 0.2% w/w between the ratios of 1:4 w/v and 1:6 w/v, then
leveled off at 10.6% w/w. Based on these results, the partitioning of each sample due to alcohol
precipitation was adjusted and normalized by eliminating the insoluble effect averaging at 11%.
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3.3.2 Yields of the Purified and Precipitant Extracts in response to Alcohol Precipitation
AP was successful in partitioning the crude extract into a soluble supernatant (the purified
extract) and insoluble precipitant. The yields of the purified extracts in the form of supernatants
decreased exponentially from 94% to 55% as the aqueous ethanol concentrations increased from
0% (control) to 95% (Fig. 3.1). The highest effect of alcohol precipitation occurred at the 95%
AP regimen, which precipitated 36% of the crude extract mass as impure components, leaving
55% of the weight in the supernatant solution, which was later dried to become the purified
extract. The unaccounted 9% was a loss during the process of filtration, concentration, or freezedrying.
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Figure 3.1. Yield of the purified extract (supernatant) as a result of alcohol precipitation (AP)
regimens (n=5). Quadratic regression model was fitted. Values are expressed as mean ± standard
error (vertical line; n=5).

3.3.3 Changes of Marker Compounds in the Purified Extract to Alcohol Precipitation
As the ethanol concentrations increased in the aqueous solutions, the contents of the combined
five marker compounds increased in the solutions (Fig. 3.2). In the 95% aqueous ethanol
solution where the content of the five markers was highest, the marker compounds accounted for
over 20% by weight of the purified extract, a significant 8% increase from the 10% AP regimen.
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To further illustrate the changing trend of each individual compound, regression models
were used to determine the relationships. Generally, all markers were continuously concentrated
by increasing AP levels, but the pace of and maximum change differed among the markers (Fig.
3.3). Among them, GA, EGA, RUB, and STM had quadratic relationships (P < 0.001)
characteristic of a slow or nearly zero rate of increase at lower alcohol concentrations followed
by a rapid rate of increase. For example, the contents of GA, EGA, RUB, and STM in the
purified extract seldom changed up to 40% AP regimens, but increased linearly and significantly
after this point to a maximum at 95% AP regimen. In contrast, the relationship of RUT and AP
regimens was linear (P <0.001). RUT content increased at a constant rate as AP regimens moved
upward. Overall, at 70% AP, the yield of GA and STM in the purified extract increased almost
10-fold compared to the raw material while the RUB concentration was 3-fold higher than the
raw leaf material (Table 3.1). The yield of RUT and EGA stayed about the same even after the
purification process possibly due to chemical properties of the compounds itself (Table 3.1).
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Figure 3.2. Changes in the contents of the total five marker compounds in the purified extract in
response to alcohol precipitation (AP). Quadratic regression model was fitted. Values are
expressed as mean ± standard error (vertical line; n=3).
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Table 3.1. The yield (% w/w) of extract and all five marker compounds in the leaf, crude, and
purified extract of the Chinese sweet tea plant (Rubus suavissimus).
Yield (% w/w)
Gallic
Acid

Ellagic
Acid

Rubusoside

Steviol
Monoside

0.13 ± 0.02 0.11 ± 0.03

0.71 ± 0.14

4.87 ± 0.80

0.08 ± 0.02

Crude
Extract

28.64 ± 1.18 0.72 ± 0.03 0.11 ± 0.00

0.87 ± 0.03

7.84 ± 0.19

0.64 ± 0.01

Purified
Extract

66.50 ± 1.23 1.03 ± 6.54 0.19 ± 0.00

0.67 ± 0.01 12.53 ± 0.06

0.96 ± 0.03

Extract
-

Raw Leaf

Rutin

GA

1.4

1.2

Y= 0.8578 - 0.004795x + 0.0001081x2
R2 = 0.9535

1.0
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0.24
0.22
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Figure 3.3. Changes of the individual marker compound in the purified extract (supernatant)
corresponding to ethanol concentrations in the AP experiments. A simple linear regression
model was fitted for RUT. Quadratic linear models were fitted for the contents of GA, EGA,
RUB, or SM. All values are expressed as mean ± standard error (n=3).
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3.3.4 Changes of Chemical Components in the Precipitant to Alcohol Precipitation
Marker compounds were minor components in the precipitant to begin with. At a low alcohol
concentration of 10%, marker compounds accounted for approximately 8% (w/w). As the
alcohol concentrations increased from 10% to 50%, the contents of the marker compounds
decreased at nearly a linear rate to 2.8%, reflecting an obviously higher affinity of marker
compounds with ethanol than with water. Further increases in alcohol concentrations of 60% or
higher caused an additional 1.2% decrease of the marker compounds, to rest at a final 1.6% in
the precipitant (Fig. 3.4).
Polysaccharide (PSAC), on the other hand, was a major component in the precipitant, a
target component to be removed by alcohol precipitation. The total polysaccharides content was
measured using the phenol-sulfuric acid colorimetric method. A standard curve (n=3) was
developed and validated using glucose as a standard compound. The R2 was 0.993 and the
recovery rate was 98.79% with a relative standard deviation (RSD) of 2.74. All polysaccharides
measurements were expressed as glucose-equivalent polysaccharide. Polysaccharides content in
the precipitant linearly increased fourfold but stopped at 70% alcohol concentration when
maximal saturation was reached (Fig. 3.4). At that point, polysaccharides accounted for 22.97%
of the precipitant and approximately 11% of the crude extract by weight. Leveling off of
polysaccharide content at the 70% AP regimen was an indication of complete removal of
polysaccharides. The observed continued slight increases in the precipitant yield were
accompanied by the slight re-bounce of the unknown components. These components analyses,
hence, demonstrated the positive effect of AP in purifying the bioactive compounds (markers) in
the sweet tea extract through the removal of polysaccharides. The other unknown constituents in
the precipitant followed the similar response patterns to the marker compounds except at 80%
AP or higher, where there was a slight re-bounce (Fig. 3.4).
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Figure 3.4. Changes in the contents of the five marker compounds, polysaccharides (PSAC), and
unknown constituents in the precipitant in response to alcohol precipitation (AP). Quadratic
regression model was fitted. Values are expressed as mean ± standard error (vertical line; n=3).

3.3.5 Chromatographic Fingerprint of the Purified and Precipitated Extracts
Fingerprints were developed for the purified and precipitated samples to gain insight into the
differences in composition benchmarked by the five marker compounds and unknown but
characteristic peaks (1-5) that responded noticeably to alcohol precipitation.
At the 10% alcohol concentration, more GA, Peak 1, Peak 2, and RUB were in the
supernatant solution than in the precipitant; less Peak 3, Peak 4, RUT, and Peak 5 were in the
solution than in the precipitant; much less EGA was in the solution than in the precipitant; and
SM was equal in the solution and precipitation (Fig. 3.5A). At the 50% alcohol concentration,
the majority of GA, Peak 1, Peak 2, Peak 3, and RUB were in the supernatant solution; Peak 4,
RUT, and Peak 5 were equally split between the solution and precipitant; more EGA was in the
precipitant than in the solution; and SM was all in solution (Fig. 3.5B). When the alcohol
concentration increased to 95%, some obvious shifts of partitioning patterns were observed. GA,
Peak 3, RUT, Peak 4, Peak 5, and RUB were almost completely in solutions, similar to STM
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already started at the 50% AP regimen (Fig. 3.5C). Peak 2 remained unchanged. Conversely,
Peak 1 and EGA changed to opposite directions relative to their responses to 50% alcohol
concentration. Most of Peak 1 (or the component it represented) went to the precipitant at the
95% AP regimen, whereas most of it stayed in the solution at the 50% AP regimen. While more
EGA was in the precipitant at the 50% AP regimen, it was apparently much less at the 95% AP
regimen.
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Figure 3.5. Chromatographic fingerprint of the Chinese sweet leaf tea (Rubus suavissimus)
extracts subjected to alcohol precipitation (AP). Selected chromatograms demonstrate the
partitioning of the five marker compounds between the supernatant (S) and precipitant (P)
fractions as results of 0% EtOH (RUS-0), 50% EtOH (RUS-50), or 95% EtOH (RUS-95)
treatments. Presence of the five marker compounds is indicated as gallic acid (GA), rutin (RUT),
ellagic acid (EGA), rubusoside (RUB), and steviol monoside (SM). Peaks 1- 5 are unknown
compounds. NOTE: Alignment may be slightly off for some fingerprints due to graphic
demonstration purpose.
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3.4 Discussion
Alcohol precipitation allows the separation of small molecules from polymers, and therefore is a
useful initial purification procedure for desired chemical compounds. This procedure has been
applied in many studies to separate biologically active polysaccharides (Schmourlo et al., 2005;
Wu et al., 2007; Yang et al., 2008) from other components in botanical samples. In our current
study, however, we found that the bioactive compounds in the crude extract of the Chinese sweet
tea plant are secondary metabolites with low molecular weight, rather than those of
macromolecules such as polysaccharides. Thus, in order to eliminate polysaccharides or other
polymers in the crude extract prepared by boiling water, a simple yet effective method was
sought to purify the bioactive small molecules in the crude extract. In this study, the alcohol
precipitation method, commonly used to obtain pure polysaccharides, was examined for its
effectiveness of removing rather than purifying polysaccharides from the crude water extract of
the Chinese sweet leaf tea. Schmourla et al. (2005) demonstrated that there was a clear difference
of antifungal activity in medicinal and food plants between the supernatant and precipitant
phases using AP as a purification procedure. The separation which resulted from their respective
study did enhance the antifungal activity of certain plants.
Another study on the honeysuckle flowers (Yang et al., 2006) also clearly illustrated the
improvement of chlorogenic acid purity from 31.62% to 37.72% after the precipitation of crude
extract with 60% ethanol. Our current finding that the contents of selected bioactive marker
compounds were significantly increased in a concentration-dependant manner was similar. Using
the alcohol precipitation method, the crude extract of sweet tea was purified by one-fold through
the removal of 11% polysaccharides and other yet-to-be identified components. The separation
of mass to this magnitude by a single step shows the efficiency and cost-effectiveness of alcohol
precipitation in obtaining purer botanical samples.
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Most interestingly, the degree of purity of the finished product can be readily controlled
so that the purified extract contains the levels of desired components. For example, to safely
remove all polysaccharides without removing unnecessary unknown components, 70% alcohol
concentrations would be sufficient and appropriate, and alcohol strength higher than 70% would
cause additional precipitation of unknown components, such as that represented by Peak 1.
Although the exact mechanism is unknown, it may be due to the intrinsic affinity nature of the
compound itself in Peak 1. While Peak 1 was found highest in the supernatant at 70% ethanol,
either too high (e.g., 95%) or too low (e.g., 10%) returned this compound to the precipitant.
Apparently, this compound has higher affinity to water than to the ethanol. Another example in
our study was EGA (ellagic acid) where the absorption peak was found highest in the precipitant
at 10% alcohol. In fact, as the concentration of ethanol increased from 10% to 95%, the EGA
content decreased by almost 15-fold in the precipitant. On the other hand, in the supernatant
solution, the yield of EGA increased with the alcohol regimens and then reached a plateau at
80% AP. These phenomena clearly suggested greater affinity of EGA to ethanol than water. Liu
(2007) also reported that most starch, protein, polysaccharides, inorganic salts, or other polymers
can be removed by AP when using 80% ethanol. Due to the concern of losing small molecules
with high alcohol concentrations (e.g., higher than 80%), 60% to 75% ethanol is usually
recommended to avoid additional loss of bioactive metabolites (Liu, 2007) Therefore, our
detailed quantitative and qualitative fingerprint analyses over the fractionated extracts as a result
of alcohol precipitation provide the best understanding of the partitioning behaviors of each
known component as well as some unknown compounds so specific alcohol precipitation
regimens can be adopted for the desired extract purity and composition.
The crude extract of the Chinese sweet leaf prepared by boiling water contained
approximately 11% w/w of polysaccharides as determined by the phenol-sulfuric acid
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colorimetric method. Phenol-sulfuric assay is a simple, convenient, and sensitive method to
measure the concentration of polysaccharides in plant extracts. The reaction mechanisms may
involve the condensation with phenol after the parallel dehydrations of carbohydrates with
sulfuric acid (Scherz et al., 1998). Under a proper condition, the phenol-sulfuric colorimetric
method has approximately ±2% of accuracy (Hodge and Hofreiter, 1962) and has also been
applied in microplate format due to its simplicity and sensitivity (Masuko et al., 2005). Our
study indicated that the recovery rate of the phenol-sulfuric acid colorimetric method was
98.79% with an RSD of 2.74. These data confirm the validity of this method in measuring the
content of polysaccharides in complex botanical samples.
Purification of crude plant extracts is widely used in botanical research to augment the
initial observation of biological activities. Chou et al. (2009) have presently developed a
validated HPLC method in assessing the quality of the Chinese sweet leaf tea extract possessing
multiple bioactivities. This would further help us to quantify and qualify the end products
resulted from AP. Because the stability, safety, and effectiveness of AP depend on several
factors such as the extract concentration, alcohol volume and concentration, reaction time length,
temperature, stirring procedure during precipitation, and chemical and physical properties of raw
material used in precipitation (Liu, 2007), it is important to verify and control the overall quality
and thus the bioactivity of the extracts under the conditions of AP. In the study of antifungal
activity, Schmourla et al. (2005) demonstrated the lost activity in some medicinal plants after the
separation of the plant extracts into precipitant and supernatant. The crude aqueous extract of the
Chinese sweet leaf displayed potent antiangiogenesis activities due to the presence of gallic acid
(Liu et al., 2006). Therefore, to purify the crude sweet leaf tea extract for increased
antiangiogenesis activity, achieving an increased level of gallic acid is clearly desirable. On the
other hand, since gallic acid is not the only compound that explained the overall antiangiogenic
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activity of the sweet leaf tea extract, it is imperative to retain other possible bioactive compounds
until proven not useful. This also further explained the reasons we adopted a longer analytical
time (100 min) to our HPLC methods which would help us optimize the separation of
compounds, known or unknown, that may exhibit bioactivity (Chou et al., 2009). In addition to
the quantity of each known marker compound, the ratios of these compounds are of great
importance to us because of the prospect of concerted action potential. This argument might be
exemplified by the observed lost activity in some medicinal plants after AP regimens
(Schmourlo et al., 2005), which could be a result of changes of the ratios of active compounds
that could have modified the intrinsic synergistic or additive properties. Because the alcohol
precipitation used in this study resulted in a whole spectrum of extracts differing in ratios, thus in
composition, these samples warrant differential bioactivity examinations. For this purpose,
detailed fingerprint analyses over the results of a simple purification procedure were proven
worthy.
3.5 Summary
This is a first report on the purification of sweet leaf crude extract using alcohol precipitation.
Our study confirmed a clear separation of selected marker components from polysaccharides in
response to alcohol precipitation. The level of rubusoside, one of the marker compounds and the
characteristic sweetening agent, was doubled in a 95% alcohol solution via a complete removal
of 11% polysaccharides and other macromolecules or ethanol insoluble components. Overall,
70% to 80% EtOH was the best range for purifying the five markers without risking the loss of
many unknown compounds. By employing this purification method, a significantly purer extract
can be obtained for potential improved bioactivity. Alcohol precipitation, therefore, proves to be
a useful tool in purifying polysaccharide-rich plant extracts such as the sweet leaf tea extract.
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CHAPTER 4. ABSORPTION OF BIOACTIVE COMPONENTS IN THE CHINESE
SWEET LEAF TEA EXTRACT (RUBUS SUAVISSIMUS S. LEE) AND ITS ANTIOBESITY EFFECT IN NORMAL RATS
4.1 Background
The prevalence of overweight and obesity are growing worldwide, overtaking the incidences of
underweight, malnutrition, and other infectious diseases. It is estimated that there were over one
billion of overweight individuals and more than 300 millions who are obese (Aronne, et al.,
2007). Generally, obesity is defined by the body mass index (BMI) greater than 30 kg/m2. In
addition to body weight gain, obesity also causes the accretion of adipose tissues where health
may be adversely affected (Frühbeck, 2008). Nonetheless, obesity also increases the risk of other
health-threatening diseases such as diabetes, hypertension, cardiovascular disease, and
cerebrovascular disease (Haslam et al., 2005; Aronne et al., 2007; Shah et al., 2008).
Search for ways to manage a healthy body weight has been a thirst for individuals and
biomedical researchers. Because of the lack and limitation of weight loss medicines, traditional
herbal medicines and food ingredients that are physiologically functional become once again
important sources of weight management agents. There were numerous reports on the weight
loss and treatment of metabolic disorders via the application of functional foods and herbal
medicines (Han et al., 2002; Park et al., 2006; Choi et al., 2007; Ekanem et al., 2007; Lei et al.,
2007; Lemaure et al., 2007; Kamisoyama et al., 2008; Lee et al., 2008). Among the potential
functional food ingredients, green tea (Camellia sinensis) is the one most extensively studied in
the prevention of metabolic syndrome (Dulloo, 1999; Sayama et al., 2000; Zheng et al., 2004;
Nagao et al., 2007; Boschmann et al., 2007; Bose et al., 2008; Ito et al., 2008; Maki et al., 2009;
Nagao et al., 2009). Studies have shown that green tea increases fat oxidation and thermogenesis,
contributing to the weight reduction in obese men (Dulloo, 1999; Boschmann et al., 2007). Other
food and herbal ingredients, such as ginger roots (Zingiber officinale) (Al-Amin et al., 2006;
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Goyal et al., 2006), capsaicin or capsinoids (Snitker et al., 2009; Hsu and Yen 2007; Kang et al.,
2007), fenugreek (Handa et al., 2005; Srichamroen et al., 2009; Jette et al., 2009), and ginseng
(Panax ginseng) (Kim et al., 2002; Xie et al., 2002) have shown anti-obesity effects. The most
effective herbal agents were perhaps ephedrine and caffeine, alone or in combinations. For
several years, ephedrine and caffeine have been used as dietary supplements for weight loss until
toxicity issues prompted the Food and Drug Administration (FDA) to halt their use for this
purpose. Currently, there are no effective and safe herbal products for weight management
despite numerous and tireless research efforts. Consequently, the search continues and prompts
the investigation of this special folk medicine commonly known as the sweet leaf tea (Rubus
suavissimus), one of the many Rubus species in the Rosaceae family.
Rubus species have long been used as traditional medicines for therapeutic purposes. For

example, Rubus ideaus (Morimoto et al., 2005), Rubus imperialis (Novaes et al., 2001), Rubus
fructicosis (Jouad et al., 2002), and Rubus fruticosus (Alonso et al., 1980; Swanston-Flatt et al.,
1990) showed hypoglycemic effects through the reversal of insulin resistance. Moreover, the
black raspberry extracts (Rubus occidentalis) displayed anti-angiogenesis (Liu et al., 2005) and
anti-cancer (Wada et al., 2002) properties. As a traditional folk remedy, R. suavissimus has been
widely applied in southwestern China to treat various diseases such as type 2 diabetes. Recent
scientific investigations found that the leaf extract of R. suavissimus was highly potent against
angiogenesis and gallic acid in the extract was partially responsible (Liu et al., 2006). Other
studies also demonstrated that the sweet leaf tea extract was inhibitory of the activity of NF-κB
(Liu et al., 2005) and α-amylase (Li et al., 2007), which are closely related to glucose
metabolism.
Recent scientific evidence has linked excessive blood vessel growth to diseases such as
cancer, obesity, and asthma (Fan et al., 2006, Brakenhelm et al., 2008). Rupnick et al (2002)
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showed that the use of an angiogenesis inhibitor caused weight loss whereas treatment
withdrawal restored body weight gain, suggesting obesity or fat accumulation is dependent on
angiogenesis. Studies also supported that antiangiogenic therapy has successfully inhibited the
process of adipogenesis and the growth of pre-existing adipose tissues (Rupnick et al., 2002; Liu
et al., 2003; Brakenhielm et al, 2004; Brakenhielm and Cao, 2008). Since the leaf extract of R.
suavissimus was a potent angiogenesis inhibitor (Liu et al., 2006; Oner et al., 2007), a hypothesis
emerged that it has the potential to cause significant weight loss. In addition to the angiogenesis
inhibition, its identified ingredients, such as gallic acid and ellagic acid, were reported to reduce
the α-amylase and bacterial activities, both of which could contribute to reduced energy
absorption. The antiangiogenic effects, the inhibition of NF-κB (Liu et al., 2005) and α-amylase
(Li et al., 2007) activities, and anti-bacterial effects of the sweet leaf tea extract may work in
concert to produce a significant overall weight loss effect. This study was therefore designed to
determine the bioavailable components in the sweet leaf tea extract and whether these
compounds could cause significant weight loss at a non-toxic dose.
4.2 Materials and Methods
4.2.1 Reference Standards
Gallic acid (GA), rutin (RUT), and ellagic acid (EGA) were purchased from Sigma Chemical
Company (St. Louis, MO). The reference standards of rubusoside (RUB) and steviol monoside
(STM) were isolated by our own lab and were identified by spectral data (UV, MS, 1H NMR, 13C
NMR and 2D-NMR). Both RUB and SM have purities greater than 98% by HPLC–PDA
analyses based on a peak area normalization method.
4.2.2 Extracts
The standardized Chinese sweet leaf tea extract (RUS; batch # XRUS0505) was processed by
our own laboratory. The quality of the extract is monitored based on the yield of the five major
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compounds (i.e., gallic acid, ellagic acid, rutin, rubusoside, and steviol monoside) via the
analyses of HPLC.
The purified Chinese sweet leaf tea extract (GER) was composed of 1.38% w/w of gallic
acid, 2.4% w/w of ellagic acid, and 23.41% w/w of rubusoside. These compositions were similar
to those found in the standardized leaf extract (RUS) as shown in Fig. 4.1.
4.2.3 Animals
All Sprague-Dawley rats used in the experiments were purchased from Harlan (Harlan,
Indianapolis, IN). Animals were housed individually in a stainless steel cage in an airconditioned room at 21°C ± 2°C, 50-60% relative humidity, and 12/12 h light/dark cycle. Prior
to the euthanization, urine was collected from each rat through an individual metabolic cage (Lab
Products Inc, Seaford, DW). Blood or serum was collected via cardiac puncture. All procedures
were performed under the approved protocols by the Institutional Animal Care and Use
Committee of Louisiana State University (LSU-IACUC), Louisiana, USA.
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Figure 4.1. Chromatographic fingerprint of the purified Chinese sweet leaf tea (Rubus
suavissumus) extract (GER) composed of gallic acid (GA), ellagic acid (EGA), and
rubusoside (RUB) in a composition equivalent to the total extract (RUS).
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4.2.4 Diets
All rats were fed either with freshly prepared AIN-93G purified liquid diet (Dyets Inc,
Bethelem, PA) or standard chow (Purina 5001 Lab Diet, PMI Nutrition International,
Brentwood, MO). The liquid diet was prepared at a concentration of 0.1755g/ml with tap water.
The ingredients of the liquid diet are shown in Table 4.1 where each mL of the liquid diet
accounting for 1 calorie with 64% of total calories from carbohydrates, 19.3% from protein, and
16.7% from fat. On the other hand, the standard chow was composed of 58% carbohydrates,
28.5% protein, and 13.5% of fat in each calorie.
Table 4.1. Compositions of the AIN-93G purified liquid diet
Ingredients
Casein

grams/Liter of Diet
53.00

Sucrose

26.50

Cellulose

13.30

Maltose Dextrin

135.40

Soybean Oil

18.60

t-Butylhydroquinone

0.004

(TBHQ)
AIN-93G Salt Mix

9.28

AIN-93G Vitamin Mix

2.65

L-Cystine

0.80

Choline Bitartrate

0.66

Xanthan Gum

3.00

4.2.5 Absorption of Marker Compounds in the Chinese Sweet Leaf Tea in Normal SD Rats
via Oral Gavage
Thirty-two normal male Sprague-Dawley (SD) rats (3 to 6 week-old) were divided into two
groups receiving either extract or blank diet. Prior to treatment, all rats were fasted overnight for
18 hours. The treated group (n=25) was administered with extract at a concentration of 0.1%
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w/w (1g of extract/kg of body mass) via daily gavage for 3 consecutive days. The control group
(n=8), on the other hand, was fed with standard chow (Purina 5001) and water as vehicles. Urine
was collected cumulatively for 24 hours, a day before euthanization, through an individual
metabolic cage.
4.2.6 Determination of Extract Delivery Methods
To ensure a non-stressful oral intake of extract, different extract delivery methods were
examined using nine 6-8 week-old male SD rats. Delivery methods tested included the oral
feeding method through water (as drink), powdered diet (Dyets Inc, Bethelem, PA), liquid diet
(Dyets Inc, Bethelem, PA), and non-fat dairy yogurt (purchased from local grocery store). These
methods were tested by mixing or dissolving the extract in the respective form of food or water.
Prior to the feeding, each rat was fasted overnight for 18 hours. Extract was mixed at a
concentration of 30mg/ml or 30mg/g and delivered either through a 15-ml tube (Fig. 4.2) or a
feeder. Extract delivered by water was tested on all rats at Day 1 and Day 2. The same group of
rats was again divided into 3 groups at day 3 and day 4 to receive extract-containing diet
delivered through powdered diet, liquid diet, or non-fat dairy yogurt, respectively. Consumption
of extract for each delivery method was recorded at 30 min and 60 min. Acceptance of delivery
method was determined based on the consumption rate or amount of extract consumed.

Figure 4.2. A 15-ml Falcon™ tube used in the extract delivery.
4.2.7 Determination of Minimal Effective Dose for the Chinese Sweet Leaf Tea Extract
A 5-day absorption study was conducted on the same group of SD rats to determine the excretion
of each marker compound (in their original structures) in the urine sample. After an overnight
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fasting, all rats were fed with extract at a concentration determined earlier (30mg/ml) for 60 min.
Amounts of extract consumed were recorded daily. Subsequently, the rats were fed with regular
liquid food throughout the day cycle for 8 hours. A 24-hour urine was collected daily and stored
at -20°C until analyzed. Concentrations of each marker component were analyzed with the
HPLC and excretion rates of selected marker compounds were calculated to develop a doseresponse curve within the range of dosages consumed by the animals during the 5 consecutive
days.
4.2.8 The Anti-obesity Effect of the Chinese Sweet Leaf Tea Extract in Normal SD Rats
4.2.8.1 Experimental Design
To observe the weight loss effect resulted from the administration of Chinese sweet leaf tea
extract, 25 normal SD rats were divided into 3 groups, which include a control group and 2
treated groups, with 8 rats in each treated group and 9 rats in the control group, as shown below.
•

Group 1 (RUS): Treated group receiving the standardized Chinese sweet leaf tea extract

•

Group 2 (GER): Treated group receiving the purified Chinese sweet leaf tea extract

•

Group 3 (CTR): Control group receiving blank liquid food as vehicle

To ensure a non-stressful administration of extract, voluntary oral feeding method was selected
as a delivery method in this study by dissolving the powdered extract in liquid food at a
concentration of 30 mg/ml. The amount of extract was pre-determined and adjusted based on the
body weight of each rat.
Prior to the initiation of treatment, one-week adaptation period was employed as an adaptation to
the liquid food and extract. A single administration of crude extract was given at 0.5 g per kg of
body weight for 74 days. The GER, which accounts for 27% of the extract by weight, was given
at a dosage of 0.14g/kg of body weight (equivalent to the extract dosage of 0.5g/kg of body
weight). All rats were given ad lib access to liquid food for 8 hours (day cycle) after the
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consumption of extract or compounds mixture. Fasting period started at 6 pm each day until 9
am the next day. Food intake was measured daily and body weight was recorded every two days.
Animals were observed daily for any abnormal physical and behavioral changes or signs of
toxicity, including posture, rough hair coat, decreased responsiveness, and unusual breathing
pattern, etc.
4.2.8.1.1 Adaptation Period
To reduce the effect of extract aversion, a one-week adaptation to the liquid food and extracts
was employed. All rats were fasted overnight for approximately 18 hours prior to the feeding of
liquid food or extracts. Replacement of liquid food with extracts began only until a constant rate
or improvement of liquid food consumption was observed. Administration of extracts were
conducted by dissolving the leaf extracts (in powder form) or the compounds mixture in the
liquid food and then delivered through a 15-ml falcon™ tube at a concentration of 30mg/ml.
Extract volume was pre-determined based on the body weight. Concentration of extract was
diluted initially to avoid aversion to the novel taste and was adjusted constantly as stable
consumption rate was observed. Extract dose consumed was recorded daily for future references.
4.2.8.1.2 Treatment Period
4.2.8.1.2.1 Daily Administration of Extract
A single administration of extract started at 9 am daily. Extract-containing liquid food, at a predetermined volume based on body weight (0.5g/kg of body mass), were given to the treated
groups, corresponding to the treatment. Blank liquid food was given to the control group as
vehicle. All tubes were pre-measured and final weight of the tubes was recorded to calculate the
actual dosage consumed. Subsequently, all rats were given ad libitum access to the liquid food
during the day cycle for 8 to 9 hours and then fasted overnight.
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4.2.8.1.2.2 Measurement of Body Weight
Body weight of each rat was measured every two days prior to the feeding of extract or food.
Cumulative body weight (CBW) changes were calculated based on the initial fasting body
weight as shown below:
CBW = [Current Body Weight (g) – Initial Body Weight (g)] / Initial Body Weight (g)
4.2.8.1.2.3 Measurement of Food Intake
Each rat was given ad libitum access to liquid food during the day cycle from 9.30 am (or upon
completion of extract) to 6 pm daily via a glass water bottle. The weight of a water bottle with
liquid food was pre-measured prior to the feeding and the final weight of the water bottle with
liquid food was recorded to determine the total consumption of liquid food during the day cycle.
Relative daily food intake (%) was calculated to determine the effect of extract administration on
daily food intake. Calculation of the relative daily food intake is shown below:
Relative Food Intake (%) = Total Food Intake (g; dry liquid food) / Body Weight (g)*100%
4.2.8.1.2.4 24-hour Urine Collection
Urine was collected after 6 week of extract administration. At the day of urine collection, each
rat was placed immediately in a metabolic cage (Lab Products, Inc. Seaford, DW) after
administration of extract or liquid food to collect the 24-hour urine. Urine samples collected
were stored in the refrigerator at -20ºC until analysis.
4.2.8.1.3 Treatment Withdrawal
A four-week recovery period was conducted to further observe the body weight regain ability of
the animals after the withdrawal of treatments. During this period, rats were fed with standard
chow and water for 24 hours. Body weight was recorded weekly. The recovery period was
divided into two phases, where each phase consisted of two weeks. During the first phase of the
recovery period, rats had free access to food and water, without receiving any treatment, to
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determine the ability of weight recovery. This phase also referred to as the blank period. At the
second phase, rats received extract or compounds mixture daily with ad libitum access to food
and water to further observe the phenotype effect after a two-week blank period or treatment
withdrawal. Throughout the recovery period, all rats were not fasted overnight.
4.2.8.1.3.1 Blood Sampling and Clinical Pathology
At the end of the recovery period, rats were anesthetized with isoflurane and euthanized. Blood
samples were collected from each group to examine any possible of toxicity or adverse effects
that resulted from the consumption of the extracts. For the hematology analysis, blood samples
were collected in an EDTA vacutainer (Beckin, Dickinson and Company, Franklin Lakes, NJ).
The parameters tested included the RBCs, hemoglobin, hematocrit, red blood cell distribution
width (RDW), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean
corpuscular hemoglobin concentration (MCHC), platelet count, mean platelet volume (MPV),
and total WBCs. For the chemistry analysis, blood samples were collected in a vacutainer and
were allowed to coagulate. Serum was separated via centrifugation at 2000 × g for 10 min.
Serum chemistry tested included serum glucose, alanine aminotransferase (ALT), aspartate
aminotransferase (AST), alkaline phosphatase (APH), urea nitrogen (BUN), and creatinine. Both
blood and serum samples were stored at -20°C and immediately submitted to the Louisiana
Animal Disease Diagnostic Laboratory (School of Veterinary Medicine, Louisiana State
University, Baton Rouge, LA) for analysis.
4.2.9 Statistical Analysis
Data were analyzed with Statistical Analysis System (SAS, Cary, NC). Regression models were
fitted to determine the relationship between the concentration of marker compounds and dosage
levels in the 24-hour urine sample. On the other hand, analysis of variance (ANOVA) with
repeated measure was performed on the body weight changes and relative daily food intake.
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Parameters resulted from serum and hematology tests were evaluated statistically for differences
between the control and treated group using the one-way ANOVA. Tukey’s post hoc test was
performed on all tests to compare the group differences. Significance of all tests was set at p ≤
0.05. Outlier detection was performed and data was eliminated only when the R-student scores ≥
2.50 and improvements were significantly observed in the coefficient of variation, R-square, and
the test of normality. Power analysis was also conducted, with the variations resulted from
current study, to further determine the sample size required to achieve significant results. All
results reported were expressed as mean ± SEM, unless otherwise stated.
4.3 Results
4.3.1 Absorption of Several Chinese Sweet Leaf Tea Components in Normal SD Rats via
Oral Gavage
After a single administration of Chinese sweet leaf tea extract at the dose of 1g/kg of body
weight, three out of five marker compounds were detected in their original structures
(unmetabolized) in the 24-hour urine, namely gallic acid (GA), ellagic acid (EGA), and
rubusoside (RUB) (Fig. 4.3). Neither RUT nor STM were detected in the 24-hour urine sample.
Unmetabolized GA in the urine amounted to 91.7 µg, which was about 4.5% from orally
administered 2028 µg. Unmetabolized EGA and RUB in the urine were 13.3 µg and 65.3 µg,
accounting for 2.2% of orally administered 603 µg and 0.3% of orally administered 21808 µg,
respectively. However, it was observed that oral gavage itself increased the distress level, which
eventually causes removal of subjects. This phenomenon further increased the sample variation,
suggested that this route of administration may have affected the accuracy of the results.
4.3.2 Determination of Extract Delivery Method
In order to reduce the variation arising from the oral gavage, a non-stressful voluntary oral
feeding method was developed using nine previously untreated SD rats. Table 4.2 demonstrated
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the improved coefficients of variation (CV) as a result of administration method change. With
the voluntary oral feeding method, the CV was reduced by 27%, 32.4%, and 6.6% for GA, EGA,
and RUB, respectively. This new P.O. method consisted of mixing the extract with a liquid food
at the concentration of 30 mg/ml. Within 30 minutes, all rats generally consumed 7.68 ± 1.11g
extract-containing liquid foods. By controlling the volume of the extract-containing liquid food,
approximately 0.5g/kg extract dose was delivered to the rats at minimal stress. The consumptions
of extract via drinking, yogurt, and powder diet were 0g, 0.84 ± 0.81g, and 3.86 ± 0.57g,
respectively. Due to the convenience as well as the acceptance of the delivery method, the liquid
diet was selected for further animal studies.
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Figure 4.3. Chromatogram fingerprint of the standardized Chinese sweet leaf tea (Rubus
suavissimus) extract (RUS), the control and treated (RUS) urine samples indicating the presence
of the three major marker compounds, gallic acid (GA), ellagic acid (EGA), and rubusoside
(RUB) obtained from the normal SD rats after a single oral administration of 0.5g/kg via oral
gavage or blank diet.

49

Table 4.2. Comparison of the coefficient of variation of the recovery rate of gallic acid (GA),
ellagic acid (EGA), and rubusoside (RUB) in the urine samples after a single administration of
extract via oral gavage or voluntary oral uptake.
Coefficient of Variation
Oral
Voluntary
Gavage
Oral Uptake
GA

63.85
(n=18)

46.15
(n=20)

EGA

82.46
(n=17)

56.53
(n=20)

RUB

67.62
(n=17)

63.16
(n=18)

4.3.3 Determination of the Minimal Effective Dose for the Chinese Sweet Leaf Tea Extract
Fig. 4.4 demonstrated the urinary excretion of the three main markers in the sweet leaf tea
extract after a single oral administration to the normal SD rats. Twenty-four hour urine was
collected from each rat for five consecutive days. The dosages consumed ranged from 0.3 g/kg to
1.4 g/kg of body weight. A quadratic regression was developed for each marker compound to
determine the relationship between the dosage levels and the urinary excretion of the respective
marker compound. Apparently, the excretion of total GA (p = 0.0418) and EGA (p = 0.0003)
reached their maximum levels between the doses of 0.4 g/kg to 0.5 g/kg of body weight. While
the level of GA decreased almost linearly with the oral dosage level, the EGA level decreased
rapidly at lower dosage level (i.e., at the dose of 0.4 g/kg to 0.6g/kg) followed by a slow rate of
decline as oral doses increased. The amount of RUB, on the other hand, appeared to be constant
at 0.6% w/w even when oral doses increased to 1.4 g/kg (p = 0.9861). Current results revealed
that the accumulative amounts of GA and EGA in the urine were dose-dependent but that of
RUB in the urine was dose-independent. Overall, the highest amounts of GA, EGA, and RUB
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were achieved by orally administering the sweet leaf tea extract at a 0.5g/kg dose. Based on this
determination, the extract dose of 0.5g/kg body weight was chosen for the weight change study.
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Figure 4.4. Recovery rates (%) of the unmetabolized gallic acid (GA), ellagic acid (EGA),
and rubusoside (RUB) in the urine after a single oral administration of the Chinese sweet
leaf tea extract (R. suavissimus) at random doses ranged from 0.3 to 1.5 g/kg of body weight.
Quadratic regression was fitted for each compound (Y = recovery rate; x = dose).
4.3.4 Changes in Body Weight and Food Intake in Normal SD Rats Orally Administered
the Sweet Leaf Tea Extract
Changes in the cumulative body weight gain of the treated groups in comparison with the control
group were shown in Fig. 4.5. To best illustrate the response patterns, the overall body weight
gain was divided into 3 phases based on the differences in the rate of body weight gain. Phase 1
was an accelerated growth period where there were no differences in body weight gain between
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the treated and the control group. It was during the second phase that the rate of body weight
gain started to deviate among the groups (Table 4.3). The deviation in body weight gain of both
RUS and GER began at week 3 after a single administration of the extract at a dose of 0.5 g/kg
of body weight and widen to an approximately 5%. The weight gain difference became stabilized
in Phase 3 to 6.71% from the RUS group and 6.02% from the GER group. It is also interesting to
show that the effect of GER on the body mass was comparable to the standardized Chinese sweet
leaf tea extract. Although the treatments caused about 6% weight loss, it was not statistically
different.
Food intake, overall, was not affected by the RUS or GER treatments and each animal
consumed diet approximately 5% of their body weight. Despite the significant differences in the
relative food intake caused by the initial exposures of rats to RUS and GER (Fig. 4.6), it was
mostly attributed to the early phase taste adaptation.
4.3.5 Effect of the Treatment Withdrawal on Body Weight and Food Intake
Since the weight loss effect was stabilized to non-significant 6%, a spontaneous idea came to
examine if the RUS and GER withdrawal from the diet for two weeks could result in the
regaining of lost weight. As shown in Fig.4.7, body weight regained to the level comparable to
the control group. More interesting, the resumption of RUS or GER treatment for the following
two weeks had no effect, indicating a phased in effect as previously shown (Fig. 4.5).
4.3.6 Toxicology of the Chinese Sweet Leaf Tea Extract in Normal SD Rats
Oral administration of the extracts was well-tolerated for the entire 10-weeks experiment. There
were no observed clinical signs of toxicity or any adverse effects. No significant results were
observed between the treated and the control group in hematology (Table 4.4) or serum
chemistry (Table 4.5) except that the BUN level in the RUS group was significantly lower than
the control group. Yet, the variation was marginal and therefore may not be treatment-related.
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Figure 4.5. Effects of the standardized Chinese sweet leaf tea (Rubus suavissimus) extract (RUS)
and the purified extract (GER) on cumulative body weight changes (%) in male SD rats fed with
normal diet for 11 weeks. Vertical bars at each data point represent one unit of standard error of
the mean (n=8 for RUS and GER group; n=9 for CTR group).

Table 4.3. Weekly differences in body weight changes between the treated groups (RUS and
GER) and the control group at three different phases. At phase 3, differences between treated and
control groups were averaged over time. All values were expressed as means or mean ± standard
error (n=8 for RUS and GER group; n=9 for CTR group).
Phase 1
Differences
between

Phase 2

Phase 3

Week
1

Week
2

Week
3

Week
4

Week
5

Week
6

CTR-RUS

0.78

0.11

1.47

4.54

5.54

6.49

6.71 ± 0.99

CTR-GER

-0.31

-0.30

1.01

4.00

4.01

5.51

6.02 ± 1.44
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Figure 4.6. Effects of the standardized Chinese sweet leaf tea (Rubus suavissumus) extract
(RUS) and the purified extract (GER) on the relative daily food intake (%) in male SD rats fed
with normal diet for 11 weeks. Vertical bars at each data point represent one unit of standard
error of the mean (n=8 for the RUS and GER groups; n=9 for the CTR group). Different letters at
each week indicate a significant difference at p ≤ 0.05. NS represents no significant differences.
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Figure 4.7. Effects of the standardized Chinese sweet leaf tea (Rubus suavissumus) extract
(RUS) and the purified extract (GER) on body weight compared to the control group (CTR) after
two weeks of treatment withdrawal.
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Table 4.4. Effects of the standardized Chinese sweet leaf tea (Rubus suavissumus) extract (RUS)
and the purified extract (GER) on the hematology test values in male SD rats after the two weeks
of treatment withdrawal.

RUS (n=8)

Groups
GER (n=8)

CTR (n=9)

Glucose
(mg/dL)

198.75 ± 26.56

250.13 ± 25.43

188.78 ± 17.23

AST
(IU/L)

128 ± 14.66a

86.86 ± 9.51b

95.00 ± 7.88c

ALT
(IU/L)

43.75 ± 1.77

43.88 ± 2.39

44.8 ±2.88c

APH
(IU/L)

137.00 ± 5.89

136 ± 8.52

150.67 ± 7.85

BUN
(mg/dL)

19.00 ± 0.68*

21.63 ± 0.73

22.88 ± 0.72

Creatinine
(mg/dL)

0.34 ± 0.02

0.37 ± 0.02

0.31 ±0.02

Values were expressed as mean ± standard error where n=6 in the RUS group, n=5 in the
GER group, and n=7 in the CTR group, unless otherwise specified. a n=5.
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Table 4.5. Effects of the standardized Chinese sweet leaf tea (Rubus suavissumus) extract (RUS)
and the purified extract (GER) on the serum chemistry values in male SD rats after two weeks of
treatment withdrawal.

RBC
(106/µL)
Hemoglobin
(g/dL)
Hematocrit
(%)
RDW
(%)
MCV
(fL)
MCH
(pg)
MCHC
(g/dL)
Platelets
(103/µL)
MPV
(fL)
WBC
(103/µL)

RUS (n=6)

Groups
GER (n=5)

CTR (n=7)

8.13 ± 0.24

7.71 ± 0.15

7.33 ± 0.43

14.22 ± 0.44

14.48 ± 0.36

13.31 ± 0.74

42.32 ± 1.37

41.74 ± 0.90

38.31 ± 2.38

11.98 ± 0.16

11.88 ± 0.04

12.00 ± 0.16

52.53 ± 0.68

54.16 ± 0.36

52.18 ± 0.57

18.18 ± 0.28a

18.76 ±0.20

18.20 ± 0.20

34.36 ± 0.32a

34.68 ± 0.16

34.87 ± 0.31

689.67 ± 106.9

506.80 ± 96.35

595.71 ±161.29

6.64 ± 0.23a

8.34 ± 0.56

6.78 ± 0.72a

4.32 ± 0.72

3.62 ± 0.53

3.94 ± 0.78

Values were expressed as mean ± standard error where n=8 in the RUS and GER groups, and
n=9 in the CTR group, unless otherwise specified. *Value was significant (p ≤ 0.05) as
compared to the control group (CTR). a n=6. b n=7. c n=8

4.4 Discussion
Chinese sweet leaf tea has long been used as a traditional remedy to treat various diseases such
as hypertension, atherosclerosis, diabetes, and to maintain healthy kidneys and relieve coughs
(Huang and Jiang, 2002). Due to the intense sweetness, the leaves of Rubus suavissimus have
been a popular beverage leaf tea in Southern China. Reports from recent studies also suggested
that the leaf extract of the Rubus suavissimus contains anti-inflammatory, anti-allergic, and antiangiogenic properties (Ono 2002; Liu et al., 2006; Fang et al., 2008). Although inhibiting
angiogenesis could cause weight loss as shown by Rupnick et al. (2002), this is the first report
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that the standardized Chinese sweet leaf tea extract could slow body weight gain in subjects who
are on normal diet. This study revealed a potential weight loss effect in normal SD rats that were
given a standard diet (low fat) but supplemented with the sweet leaf tea extract at the dose of
0.5g/kg of body weight. Liu et al (2006) has been reported that the Chinese sweet leaf tea extract
contains anti-angiogenic properties, partially exerted by the presence of gallic acid. However,
whether angiogenesis inhibition could totally explain the weight loss effect is unknown. It is
possible that other mechanisms beyond the inhibition of angiogenesis may be responsible for the
multiple components in the extract could target multiple organs and pathways and act in different
locations.
Chou et al. (2009) revealed the presence of four major classes of components in the
Chinese sweet leaf tea extract. They are gallotannins represented by gallic acid, ellagitannins
represented by ellagic acid, flavonoids represented by rutin, and diterpene glycosides represented
by rubusoside and steviol monoside. Since our preliminary absorption study showed that rutin
and steviol monoside were not detected in the urine samples collected from the animals being fed
with the Chinese sweet leaf tea extract (Fig. 4.2), it might be possible that they were not involved
in the systemic functioning. The low absorption of rutin and steviol monoside might be the
results of biotransformation in the gastrointestinal tract. Studies have shown that rutin (Manach
et al., 1997; Jaganath et al., 2006) and steviol monoside (Geuns et al., 2007) were mainly
metabolized and absorbed in the colon and thus was slowly absorbed into the plasma. Rutin was
catabolized into 3-methoxy-4-hydroxyphenylacetic acid and 3-hydroxyphenylacetic acid in the
liver and then excreted through the urine (Jaganath et al., 2006). Since we did not measure the
metabolites of rutin in the urine nor the serum, we could not totally exclude the systemic
bioavailability of rutin. Steviol monoside, on the other hand, metabolized in the liver and
excreted through the urine in the form of steviol glucuronide (Geuns et al., 2007). This may
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possibly explain the phenomena in our current study where rutin and steviol monoside, either in
the free or conjugated form, were not detected in the urine samples. Additional studies are still
needed to further determine and verify the bioavailability of the marker components in the
experimental subjects. However, this study was designed to answer a proof-of-concept question
whether the sweet leaf tea had an effect on body weight gain and the data provided a positive
answer. Therefore, it justifies additional investigations.
In the present absorption study, only gallic acid, ellagic acid, and rubusoside were
detected in the urine of normal SD rats administered with 0.5g/kg of standardized Chinese sweet
leaf tea extract, indicating they were bioavailable through the gastrointestinal (G.I.) tract
absorption. In addition to the possibility of systemic functioning, components in the extract could
have functioned locally inside the G.I. tract system. Gallic acid and ellagic acid have been shown
to exhibit various pharmacological effects. For example, gallic acid was inhibitory of the alphaglucosidase activity, an enzyme that break down carbohydrates into the absorbable form of
glucose (Li et al., 2008) and suppressed high-fat diet-induced dyslipidemia in rodent (Hsu et al.,
2007). Ellagic acid was found partially responsible for the anti-obesity effect in mice after the
administration of ellagic acid-containing pomegranate leaf extract (Lei et al., 2007). Rubusoside
has also been reported to have anti-microbial effect in the G.I. tract when it was given a high
concentration based on a preliminary study (unpublished data). Because of the possible functions
of these compounds in local and systemic ways, it is imperative to hypothesize that the observed
weight loss effect of the Chinese sweet leaf tea might have been a collective effect of multiple
components on multiple targets at multiple sites.
Since gallic acid, ellagic acid, and rubusoside are the major components and accounted
for almost 27% by weight of the total extract, it was very intriguing to test if these tri-compounds
combination (i.e., the purified extract) could explain the weight loss effect. This desire led to a
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new formulation that consisted of a combination of gallic acid, ellagic acid, and rubusoside
(GER) at a dose of 0.14g/kg of body weight that was equivalent to the total extract of 0.5g/kg.
Surprisingly, our current resulted demonstrated that the tri-compound combination exhibited
similar weight-suppressive effect as in the total extract. This shows that the tri-compounds
combination may represent the majority of the responsible components in the Chinese sweet leaf
tea extract in suppressing the body weight gain in normal rodents. This important finding shed
directing light toward narrowing down the truly important components of the total extract. In the
present study, GER was composed of similar amount of gallic acid and rubusoside but with
higher amount of ellagic acid as in the total extract of the standardized Chinese sweet leaf tea,
which was possibly caused by the extract’s batch-to-batch variation. Free ellagic acid has been
reported to have poor water solubility (Bala et al., 2006), which makes it even harder to recover
during the process of purification or extraction. Our current study showed an increased of ellagic
acid concentration in the GER by almost five-fold higher than the total extract while the
concentration of gallic acid and rubusoside remained about the same. This may further suggest
that the variation of ellagic acid between these two samples was highly due to batch-to-batch
differences. Nonetheless, our results revealed interesting data where the GER could achieve
similar effect as the standardized sweet leaf tea extract by suppressing 6% of weight gain
compared to the control group. After all, the bottom line of the results clarified that the increased
level of ellagic acid was independent from the phenotypic response and hence, ellagic acid, in
this case, may not be a critical compound to the overall effect or was sufficient in the extract
already. More detailed investigations are warranted to determine the contribution of ellagic acid
alone or other bioactive components to the overall weight loss effect.
The combination of GER used only 27% by weight of the extract while the 70% was
excluded. Since the GER demonstrated similar effect as the total standardized extract, we
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predicted that these 70% of unknown components did not contribute to the overall weight loss
effect. If GER is proven the majority of the effectors, the use of it in place of the total extract
could be a very promising alternative as GER has an easier quality control, improved
palatability, and reduced dose burden. Hence, GER, with the strength to avoid batch-to-batch
variation often seen existent with the extract, should be considered for future studies as a
standardized Chinese sweet leaf tea extract.
Our present results discovered a possible weight loss effect by the standardized Chinese
sweet leaf tea extract. However, in addition to the extract quality control, the overall
pharmacological response may be affected by the route of administration, dosages, and number
of times administered as these factors may be critical to the metabolism and absorption of
bioactive components. Kao et al (2006) stated that the pathways or mechanisms involved in the
energy absorption may be highly dependent on the factors stated. In our first experiment, oral
gavage was selected as the route of administration. Nevertheless, the distress level resulted from
the method created a huge variation between the subjects, which yielded a coefficient of
variation in the recovery of bioactive components of more than 50% (Table 4.2). Needless to
say, complications arose from gavage led to removal of subjects from the study and ultimately
reduced the overall sample size. Thus, for a long term study, oral gavage may be labor-intensive.
To improve the variations and reduce the distress level, a voluntary oral uptake was selected for
the study. Clearly, improvement of variation was observed with the selected extract delivery
method via liquid food. Indeed, delivery of extract via liquid food or other form of diet was only
limited to certain extracts due to novel food aversion and natural taste of the extract itself. Other
methods tested on current study, such as delivery via powdered diet and yogurt, were some
alternatives. Yet, major spillage had occurred with the powdered diet during delivery which
further affected the intake of extract. The compositions in yogurt, however, may interact with the
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extract thereby affect the accuracy of the experiment. Although other delivery methods, such as
intraperitoneal or intravenous injection, may be preferred for accuracy of results, the most
abundant compounds in the extract, such as gallic acid and ellagic acid, were metabolized and
absorbed along the GI tract (Lei et al., 2003; Konishi et al., 2004). Hence, the currently used
delivery method was still satisfied from the perspective of convenience and physiological effects.
For the first time, our study revealed a possible anti-obesity effect of the Chinese sweet
leaf tea extract with an approximately 7% of weight difference compared to the control group.
Unfortunately, we were unable to show a statistically difference between the treated and control
groups (P = 0.4776). We predicted that inappropriate use of the model may have affected the
investigation of anti-obesity effect in our current study. A statistical difference and significance
may be achieved if obese model were used instead of the normal model. Secondly, a power
analysis based on the variations from current study suggested a sample size increased (n=14)
would have been needed to produce a statistically significant effect with 80% of power. In
addition, the overnight fasting, which initially designed to encourage extract intake, also may
affect the normal weight gain of all rats, thereby mask the effect of weight loss during the
treatment period. More studies with detail and valid experimental design are warranted to obtain
more valuable data in verifying the anti-obesity effect of the Chinese sweet leaf tea.
4.5 Summary
This is the first report that the Chinese sweet leaf tea extract had a possible weight loss effect on
the normal SD rats. Based on the preliminary analyses of the 24-hour urine after a single oral
administration of extract, gallic acid, ellagic acid, and rubusoside were likely functioned via
systemic and/or local approaches. Overall, the single daily oral administration of standardized
sweet leaf tea extract at 0.5 g/kg of body weight demonstrated a 6.71% weight difference
compared with the control although the difference was not statistically significant. Because the
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tri-compounds combination composed of gallic acid, ellagic acid, and rubusoside (GER)
exhibited similar effect as the standardized Chinese sweet leaf tea extract, it is possible that these
compounds may be the responsible components for the weight loss effect. However, the
mechanisms remain unknown. No sign of toxicity was observed in current study which further
verifies the safety of the Chinese sweet leaf tea extract. More studies and investigations are
warranted to further verify the weight loss effect of the Chinese sweet leaf tea extract as well as
the possible mechanism and pharmacokinetics.
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CHAPTER 5. ANTI-OBESITY EFFECT OF THE CHINESE SWEET LEAF TEA
EXTRACT (RUBUS SUAVISSIMUS S. LEE) IN DIET-INDUCED OBESE RATS
5.1 Background
Obesity is a common metabolic disease that is growing worldwide. With increased body weight
gain, obesity is a common risk factor for diseases such as diabetes, hypertension, and
cardiovascular disease due to the excessive deposition of adipose tissues (Haslam et al., 2005;
Aronne et al., 2007; Shah et al., 2008). It is believed that the accumulation of adipose tissues
may be due to an imbalance between energy intake and energy expenditure. Aronne et al. (2007)
reported that a 5 to 10% of weight reduction highly improve lipid profiles, insulin sensitivity,
and endothelial functions. Thus, lifestyle modifications, such as dietary management and
increased physical activities, are obligatory to overcome the epidemic of obesity.
With the limited weight management programs and pharmacological options, the healthconscious population is now searching for treatment alternatives in weight maintenance with an
emphasis on the application of natural products, especially functional foods. Natural products
such as the green tea (Dulloo, 1999; Sayama et al., 2000; Zheng et al., 2004; Boschmann et al.,
2007; Bose et al., 2008; Ito et al., 2008), ginger (Al-Amin et al., 2006; Goyal et al., 2006), and
capsaicin (Hsu and Yen 2007; Kang et al., 2007; Snitker et al., 2009) have shown efficacies on
reducing body weight of obese animal models. However, the scientific evidences of herbal
medicines in the prevention or treatment of obesity is still unconvincing. The most effective
herbal agents were perhaps ephedrine and caffeine, alone or in combinations. For several years,
ephedrine and caffeine have been used as dietary supplements for weight loss until toxicity
issues prompted the Food and Drug Administration (FDA) to halt their use for this purpose.
Currently, there are no effective herbal products for weight management despite numerous and
tireless research efforts. Consequently, the search continues and prompts this investigation of a
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folk medicine commonly known as the sweet leaf tea (Rubus suavissimus), one of the many
Rubus species in the Roseasae family.
As a traditional folk remedy, R. suavissimus has been widely applied in southwestern
China to treat various diseases, which include the type 2 diabetes, hypertension, and to relieve
cough. In the screening of medicinal plants, the leaf extract of the R. suavissimus was tested
positive for the anti-angiogenic activity which has been shown to be partially exerted by the
presence of gallic acid. Other studies demonstrated that sweet leaf tea extract was able to inhibit
the activity of NF-κB (Liu et al., 2005) and α-amylase activity (Li et al., 2007) where these
factors are closely related in treating or regulating glucose metabolism. Because recent report
showed a close relationship between angiogenesis and obesity (Brakenhielm 2008; Brakenhielm
and Cao, 2008), a hypothesis was formed that the leaf extract of R. suavissimus may suppress the
accumulation of adipose tissues thereby causing weight loss. In support of this hypothesis, gallic
acid and rubusoside have been shown to reduce the activity of α-amylase and bacterial activities,
which may further decrease energy absorption by blocking the nutrient breakdown in the colon.
Therefore, in addition to angiogenesis inhibition, we believe that the multiple components
obtained from the Chinese sweet leaf tea extract may work simultaneously in producing a
significant weight loss effect via specific mechanisms.
Scientific research on the Chinese sweet leaf tea, especially on the focus of
pharmacological function, has been scarce as the discovery of Chinese sweet leaf tea is novel.
Unlike the Chinese sweet leaf tea, green tea has long been a popular ingredient in either food or
the pharmacology industry, especially in countries such as Japan, China, Korea, and Morocco
(Cabrera et al., 2006). For years, epidemiological and clinical studies have been conducted on
green tea (Camellia sinensis) for various pharmacological functions such as improvement of
insulin sensitivity and glucose tolerance (Wu et al., 2004; Li et al., 2006; Nagao et al., 2009),
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protective functions on brain and pancreas (Unno et al., 2009), anti-cancer (Shirakami et al.,
2009; Yang et al., 2009), anti-inflammatory (Navarro-Peran et al., 2008) activities, and immune
system enhancement (Cabrera et al., 2006). In addition, green tea is one of the most extensively
studied plants in the prevention of metabolic syndrome by stimulating fat oxidation and reducing
body fat accumulation (Tokimitsu 2004; Nagao et al., 2007; Monteiro et al., 2008; Nagao et al.,
2009). Studies also reported that the potential role of green tea in weight loss or weight
maintenance is mainly attributed to the presence of catechins, such as the (-)-epigallocatechin-3gallate (EGCG), (-)-epigallocatechin (EGC), (-)-epicatechin-3-gallate (ECG), and (-)-epicatechin
(EC) (Cabrera et al., 2006; Wolfram et al., 2006; Thielecke and Boschmann 2009). In addition
to catechins, Zheng et al. (2004) showed that caffeine and theanine might be the compounds
responsible for suppressing the weight of obese subjects via the regulation of lipid metabolism
and thermogenesis. Results further demonstrated that the weight suppressive effect resulting
from the combination of catechins and caffeine was actually stronger than the caffeine or
catechins alone (Zheng et al., 2004). Dulloo et al. (1999) also reported a 4% increase of 24-hour
energy expenditure in a green tea-treated group where the elevation of thermogenesis may be
attributed to the synergistic effect of the green tea components (i.e., catechins and caffeine).
From previous studies, we know that gallic acid, ellagic acid, and rubusoside are the
major compounds from Chinese sweet leaf tea extract that are responsible for weight loss. Since
the presence of caffeine and catechins differentiate the Chinese sweet leaf tea from the green tea,
it is questionable whether the Chinese sweet leaf tea extract would yield a similar or increased
weight loss effect as in the green tea. Thus, in this study, green tea extract (as a positive control)
and the purified Chinese sweet leaf tea extract composed of three major marker compounds,
gallic acid, ellagic acid, and rubusoside, were fed to the obese prone Sprague-Dawley (SD) rats.
Results from this study have provided further confirmation of the anti-obesity effect on the
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Chinese sweet leaf tea extract and thus revealed a novel pharmacological function of the
respective extract beyond its historic use as a natural sweetener or beverage leaf tea.
5.2 Materials and Methods
5.2.1 Reference Standards
Gallic acid (GA), rutin (RUT), and ellagic acid (EGA) were purchased from Sigma Chemical
Company (St. Louis, MO). The reference standards of rubusoside (RUB) and steviol monoside
(STM) were isolated by our own lab and were identified by spectral data (UV, MS, 1H NMR, 13C
NMR and 2D-NMR). Both RUB and SM have purities greater than 98% by HPLC–PDA
analyses based on a peak area normalization method.
5.2.2 Extracts
The purified Chinese sweet leaf tea extract (GER) is composed of 1.38% w/w of gallic acid,
2.4% w/w of ellagic acid, and 23.41% w/w of rubusoside. These compositions were similar to
those found in the standardized sweet leaf tea (RUS) extract as shown in Fig. 5.1. Green tea
extract, on the other hand, was provided by Amax Nutrasource (Eugene, OR). The major
compositions in the green tea extract are shown in Table 5.1 and the chromatographic fingerprint
is shown in Fig. 5.2.
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Figure 5.1. Chromatographic fingerprint of the purified Chinese sweet leaf tea (Rubus
suavissumus) extract (GER) composed of gallic acid (GA), ellagic acid (EGA), and rubusoside
(RUB) in a composition equivalent to the standardized extract (RUS).
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Table 5.1. Major compositions of the green tea extract.
Content

Yield (%)

Polyphenols

50.78%

Tea Catechins

36.67%

EGC

8.57%

DL-C

3.24%

EGCG

16.51%

EC

1.87%

GCG

1.48%

ECG

5.00%
8.97%

Caffeine

9.00

Caffeine

EGCG

7.50

6.00

AU

Mix Standard
4.50

EGCG
3.00

Caffeine
1.50

GTP
0.00
0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

Minutes

Figure 5.2. Chromatographic fingerprint of the green tea powder (GTP) and the mix standard
solution composed of caffeine and EGCG.
5.2.3 Animals
Male Obese Prone Sprague-Dawley (OP-CD) rats (4-6 week old) used in the experiments were
purchased from Charles River (Charles River Laboratories International Inc., Wilmington, MA,
USA). Animals were housed individually in stainless steel cages in an air-conditioned room at
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21°C ± 2°C, 50-60% relative humidity, and 12/12 h light/dark cycle. Prior to euthanization, urine
was collected from each rat through an individual metabolic cage (Lab Products Inc, Seaford,
DW, USA) and blood or serum was collected via cardiac puncture. In addition, liver, kidneys,
gastrointestinal tract, cecum, epididymal, retroperitoneal, and perirenal adipose tissues were
weighed individually and stored at -20°C for future analyses. Cecal and fecal contents were also
collected and immediately stored at -20°C. All procedures were performed under the approved
protocols by the Institutional Animal Care and Use Committee of Louisiana State University
(LSU-IACUC), Louisiana, USA.
5.2.4 Experimental Design
Sixty rats were divided into 4 groups with 15 rats in each group. One group (n = 15) was fed
with standard (Purina 5001, Nutrition International, Brentwood, MO, USA) and others (n = 45)
with the high fat chow (Research Diets Inc, New Brunswick, NJ, USA). A small amount of
extract was also given during phase 1 (Fig. 5.3) via liquid diet (Dyets Inc, Bethelem, PA) to
reduce the aversion to the extract. Prior to the extract administration, the obese group was again
divided into three groups with two treated and one control group receiving either extract or
vehicle during the treatment period, as shown below.
•

Group 1 (GER): Treated group receiving the purified Chinese sweet leaf tea extract

•

Group 2 (GTP): Treated group receiving the green tea (Camellia sinensis) extract

•

Group 3 (HFD): Control group receiving high fat diet as vehicle

•

Group 4 (STD): Control group receiving standard diet as vehicle

Gallic acid (GA), ellagic acid (EGA), and rubusoside (RUB) were incorporated into the high fat
diet at a concentration of 1.38% w/w, 2.4% w/w, and 23.41% w/w, respectively (i.e., GER).
These concentrations were similar to the GA, EGA, and RUB found in a 3% standardized
Chinese sweet leaf tea extract diet. The designated extract diet concentration was determined
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based on the relative daily food intake as well as the acceptance of extract in order to reach the
GER dosage of approximately 0.22g/kg of body weight, which is equivalent to the standardized
extract dosage of 0.8g per kg of body weight. The GTP group, on the other hand, received green
tea extract diet at a concentration of 3.5% to reach the dose of approximately 1.0 g per kg of
body weight (0.01% w/w). All rats were provided ad libitum access to food and tap water
throughout the treatment period for 9 weeks. Body weight and food intake were measure
weekly. Fasting blood glucose level was measured at week 4 and week 8 of the treatment period,
respectively. Animals were also observed daily for any abnormal physical and behavioral
changes or signs of toxicity, including posture, rough hair coat, decreased responsiveness, and
unusual breathing pattern, etc.
5.2.4.1 Measurement of Food Intake
All rats were given ad libitum access to either high fat or standard chow diet. Food intake was
measured weekly and the relative daily food intake (%) was calculated to determine the effect of
extract administration on daily food intake. Calculation of the relative daily food intake was
shown below:
Relative Food Intake (%) = Total Food Intake (g) / Body Weight (g) * 100%
5.2.4.2 24-hour Urine Collection
At the day of urine collection, each rat was placed into a metabolic cage (Lab Products, Inc.
Seaford, DW) to collect 24-hour urine and feces after the administration of extract or food. Urine
and fecal samples collected were stored in the refrigerator at -20ºC until analysis.
5.2.4.3 Blood Glucose Measurement
Fasting blood glucose was measured to monitor the improvement of blood glucose levels after
the administration of the purified Chinese sweet leaf tea and green tea extract. Blood glucose was
measured at week 4 and week 8. Measurements obtained prior to the initiation of treatment
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served as a baseline (week 0). A small drop of blood was drawn from the tail-vein and blood
glucose levels were measured with a commercial glucometer (Abott Laboratories, North
Chicago, IL) after a 6-hour fasting during the day (8 am till 2 pm).
5.2.4.4 Blood Sampling and Clinical Pathology
At the end of the treatment, rats were anesthetized with isoflurane and euthanized. Blood
samples were collected from each group to examine any possible toxicity or adverse effects that
resulted from the consumption of the extracts. For the hematology analysis, blood samples were
collected in an EDTA vacutainer (Beckin, Dickinson and Company, Franklin Lakes, NJ). The
parameters tested included the RBCs, hemoglobin, hematocrit, red blood cell distribution width
(RDW), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean
corpuscular hemoglobin concentration (MCHC), platelet count, mean platelet volume (MPV),
and total WBCs. For the chemistry analysis, blood samples were collected in a vacutainer and
were allowed to coagulate. Serum was separated via centrifugation at 2000 × g for 10 min.
Serum chemistry tested included serum glucose, alanine aminotransferase (ALT), aspartate
aminotransferase (AST), alkaline phosphatase (APH), creatine kinase (CK), total bilirubin, total
protein, albumin, globulin, total cholesterol, urea nitrogen (BUN), creatinine, calcium,
phosphorus, sodium, potassium, chloride, bicarbonate, and anion gap . Both blood and serum
samples were stored at -20°C and immediately submitted to the Louisiana Animal Disease
Diagnostic Laboratory (School of Veterinary Medicine, Louisiana State University, Baton
Rouge, LA) for analysis.
5.2.5 Statistical Analyses
All data was analyzed with the Statistical Analysis System (SAS, Cary, NC). Analysis of
variance (ANOVA) with repeated measured was performed on the body weight changes, relative
daily food intake, and blood glucose levels throughout the experimental period. The values of
70

serum chemistry and hematology tests were evaluated statistically for differences between the
control and treated groups using the one-way ANOVA. Tukey’s post hoc test was performed on
all tests to compare the group differences. Significance of all tests was set at p ≤ 0.05. Outlier
detection was performed and data was eliminated only when the R-student scores ≥ 2.50 and
improvements were significantly observed in the coefficient of variation, R-square, and the test
of normality. All results reported were expressed as mean ± SEM, unless otherwise stated.
5.3 Results
5.3.1 Effects on Body Weight and Food Intake of the Obese SD Rats
In the present study, obesity was induced in the obese-prone SD rats by feeding high-fat diet for
14 weeks. The experimental period was divided into three phases based on the level of extract
dosages consumed. The first phase, lasted for approximately 5 weeks, was defined as an
adaptation period where minimal or no extract was administered to the treated rats (Fig. 5.3).
During the adaptation period, both the GER and GTP extracts were given to the animals as a
supplementation to eliminate possible taste aversion. At this stage, the extract was mixed in the
liquid food at a concentration of 10 mg/ml and all rats had free access to the extract during the 8hour day cycle. Fig. 5.3 showed that approximately 0.02% to 0.03% w/w of the extract
consumption was attained at the end of this phase for both the GER and GTP groups. These
levels of extract consumption affected neither the weight (Fig 5.4) nor food intake (Fig 5.5).
Deviation of body weight changes started emerging towards the end of this phase, showing 1%
and 7% less weight gain in the GER and GTP than the HFD group, respectively (Fig. 5.4). To
increase the intake levels of extract, the delivery method was changed to incorporating the
extracts into the chow diet (phase 2). A significant improvement in the extract consumption was
observed during phase 2 which signified the beginning of the 9-week treatment period (Fig 5.4).
As a result of increased extract consumption featured in the second phase, significant weight
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gain reductions in the GER and GTP groups against the HFD group were observed after a week
of extract administrations at the level of 0.05% w/w and 0.07% w/w, respectively, and the
reductions were similar as the STD group. GTP caused further reduction in body weight gain as
the dose escalated to approximately 0.08% w/w (Fig. 5.3). Furthermore, the food intake was seen
to slightly fluctuate in this phase (Fig. 5.5) due to the change of the delivery method. Food intake
became stabilized, thus consumption of extract, which symbolized the beginning of phase 3. The
third phase of the experiment was the continuation of the treatment period that lasted for 6 weeks
where the desired dosages (equivalent extract dose of 0.8 g/kg body weight for GER and 1 g/kg
of body weight for GTP) were attained (Fig. 5.3). No difference in food intake was observed in
this 6-week constant-dose treatment period among the obese groups (Fig. 5.5). The body weight
gain rates in the GER and GTP groups were significantly lowered and maintained almost
constantly at 20% and 28%, respectively. The body weight gain of the GER group was
comparable with the standard control group (STD) both shown about 20% less weight gain than
the HFD group. At week 5 of the 9-week treatment period, GTP already caused 27% (p ≤ 0.001)
and 12% (p = 0.0081) less body weight gain than the HFD and STD groups, respectively. The
reductive effect of GER and GTP on body weight gain continued after week 5, albeit at slower
rates. At the end of the treatment, a 22% (p ≤ 0.001) and a 32% (p ≤ 0.001) less body weight
gains were observed in the GER and GTP group than the HFD group, respectively. No
significant difference in body weight gain was observed between the GER and STD groups (p =
0.2511). Overall, the group on high-fat diet consumed about 4% of their body weight while that
on standard diet consumed about 6% of their body weight during the treatment period (Fig. 5.5).
Although there was a significant difference in the amount of food intake between the food types,
the difference was mainly due to the diet composition and calorie intake.
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Figure 5.3. Average oral intake (% w/w) of the purified Chinese sweet leaf tea (Rubus
suavissumus) extract (GER) and green tea (Camellia sinensis) powder (GTP) by the diet-induced
obese SD rats. All data were expressed as mean ± standard error where n=15. NOTE: The dose
of GER is expressed as the equivalent dose to the standardized Chinese sweet leaf tea extract
(RUS).
5.3.2 Effect on Organ Weight and Fat Accumulation of the Obese SD rats
Liver, kidneys, epididymal, retroperitoneal, and perirenal adipose pads were collected from the
rats at the day of euthanization. The weights of liver, kidneys, mesentery with fat, and total
abdominal fat are shown in Table 5.2. The distribution diagram of the adipose pads collected is
shown in Fig 5.6. Total abdominal fat, which consisted of the epididymal, retroperitoneal, and
perirenal fat, was remarkably reduced in the STD, GER and GTP groups by 57%, 48% and 70%,
respectively, when compared to the HFD group (Table 5.2). The reduction of fat mass was
mainly due to the reduction of retroperitoneal and perirenal adipose pads (Fig. 5.6). Mesentery
fat in the STD, GER, and GTP group was also significantly reduced by 48%, 56%, and 74%,
respectively, compared to the HFD control group. GTP-treated group, overall, had the lowest
abdominal fat. GER and STD (low-fat diet) showed the same effect on fat accumulation. The
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weight of liver and kidneys of the GER- or GTP-treated group was not significantly different
from that of the HFD group. However, the weight of the liver and kidneys in the STD group (on
low-fat diet) was much higher than the groups on high-fat diet.
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Figure 5.4. Effects of the purified Chinese sweet leaf tea (Rubus suavissumus) extract (GER)
and green tea (Camellia sinesis) powder (GTP) on body weights in diet-induced obese SD rats
compared to the control groups receiving high fat (HFD) and normal (STD) diet, respectively.
All data were expressed as the mean ± standard error where n=15. Different letters on each week
indicate a significant difference at p ≤ 0.05.
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Figure 5.5. Effects of the purified Chinese sweet leaf tea (Rubus suavissimus) extract (GER) and
green tea (Camellia sinesis) powder (GTP) on the relative daily food intake (% w/w) in dietinduced obese SD rats compared to the control groups receiving high fat (HFD) and normal
(STD) diet, respectively. All data are expressed as the mean ± standard error where n=15.
Different letters on each week indicate a significant difference at p ≤ 0.05. NS indicates no
significant difference.

Figure 5.6. Distribution diagram of the perirenal, retroperitoneal, and epididymal fat in male rat.
Reference: Remesar et al., 2002.
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Table 5.2. Effects of the purified Chinese sweet leaf tea (Rubus suavissimus) extract (GER) and
green tea (Camellia sinensis) powder (GTP) on the weight (% w/w of disemboweled body
weight (DBW)) of organs and abdominal adipose tissues in diet-induced obese SD rats compared
to the control groups receiving high fat (HFD) and normal diet (STD), respectively.
Relative
Organs/Tissues
Weight

Group
HFD

STD

GER

GTP

Liver

2.95 ± 0.17b

3.52 ± 0.23a

2.87 ± 0.06b

2.81 ± 0.21b

Kidneys

0.54 ± 0.04c

0.71 ± 0.03a

0.62 ± 0.01b

0.65 ± 0.04b

Mesentery with Fat

3.77 ± 0.71a

1.95 ± 0.44b

1.66 ± 0.07b

0.99 ± 0.21c

Total Abdominal Fat

10.07 ± 1.50a

4.37 ± 0.88b

5.28 ± 0.26b

3.03 ± 0.73c

Epididymal

3.90 ± 0.46a

1.90 ± 0.40b

2.18 ± 0.10b

1.42 ± 0.25c

Retroperitoneal

4.45 ± 0.93a

1.66 ± 0.38c

2.27 ± 0.13b

1.15 ± 0.37c

Perirenal

1.71 ± 0.30a

0.81 ± 0.16b

0.83 ± 0.04b

0.46 ± 0.14c

(% w/w)

All values were expressed as mean ± standard error where n=15. Different letters on each row indicated a significant
difference at p ≤ 0.05.

5.3.3 Effect on Blood Glucose of the Obese SD rats
Fasting blood glucose was measured after a 6-hour fasting period during the day. Fig. 5.7
showed the changes of blood glucose levels at week 0 (baseline), week 4, and week 8. With a
comparable initial blood glucose level, the glucose level of the GER group was significantly
lower (p = 0.001) than the HFD group after a 4-week administration of extract at 0.8 g/kg body
weight and a 12% reduction from its baseline blood glucose level. GTP did not significantly
lower the blood glucose level compared with the HFD group but has successfully maintained its
stability. The blood glucose lowering effect of GER, however, was statistically insignificant at
week 8. At the end of the treatment (week 8), all groups showed a significant decrease in blood
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glucose levels compared to their baselines. The glucose levels of the untreated groups (i.e., HFD
and STD groups) remained slightly higher than the treated groups. A systemic lower blood
glucose level at week 8 was observed in all groups, possibly due to the variation in the blood
drawing process.
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Figure 5.7. Effects of the purified Chinese sweet leaf tea (Rubus suavissimus) extract (GER) and
green tea (Camellia sinensis) powder (GTP) on blood glucose levels (mg/dL) in diet-induced
obese SD rats measured prior to the initiation of treatment (Wk 0), 4th (Wk 4), and 8th (Wk 8)
week during the treatment period compared to the control groups receiving high fat (HFD) and
normal (STD) diet, respectively. All data are expressed as the mean ± standard error where n=15.
Different letters on each week indicate a significant difference at p ≤ 0.05.
5.3.4 Toxicology Related to Treatments
After 9 weeks of extract administration, no clinical sign of toxicity or abnormal behavior was
observed in the treated animals. The GTP group appeared to be more physically active in general
than others based on daily observations. There were no treatment-related adverse effects
observed based on the hematology (Table 5.3) and blood chemistry results (Table 5.4).
However, elevated values of CK were observed in all groups with excessively high variations.
While the reasons were unknown, we predicted that it might be the result of instrumental error or
fluctuation. In addition, the total cholesterol level was lower in the GER and GTP groups.
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Although the BUN and creatinine levels in the GTP group were slightly different from the STD
or HFD group, the values were still within normal ranges. No other abnormal values were noted
based on existing results.

Table 5.3. Effects of the purified Chinese sweet leaf tea (Rubus suavissimus) extract (GER) and
green tea (Camellia sinensis) powder (GTP) on the hematology test of diet-induced obese rats
compared to the control groups receiving high fat (HFD) and normal (STD) diet, respectively.
Groups
HFD

STD

RUS

GTP

Erythrocyte
(106/µl)

8.09 ± 0.11 ¥

8.03 ± 0.14

8.16 ± 0.16

8.06 ± 0.11

Hemoglobin
(g/dL)

14.89 ± 0.34 ¥

14.37 ± 0.30

14.13 ± 0.34

14.59 ± 0.29

Hematocrit
(%)

42.06 ± 0.46 ¥

41.69 ± 0.93

41.62 ± 0.84

43.07 ± 0.68

RDW
(%)

11.93 ± 0.03 ¥

11.89 ± 0.08 ¥

11.90 ± 0.08 ¥

11.86 ± 0.07

MCV
(fL)

52.60 ± 0.54

52.64 ± 0.46

52.45 ± 0.58

53.62 ± 0.50

MCH
(pg)

18.04 ± 0.44

17.96 ± 0.44

16.97 ± 0.58

18.48 ± 0.16

MCHC
(g/dL)

34.66 ± 0.26

34.51 ± 0.20 ¥

34.59 ± 0.22†

34.29 ± 0.13

Platelets
(103/µl)

573.70 ± 96.80

582.20 ± 74.25

617.40 ± 94.05

625.60 ± 57.29

MPV
(fL)

7.07 ± 0.41 ¥

7.28 ± 0.50

7.53 ± 0.54

7.37 ± 0.42

Total WBC
(103/µl)

3.55 ± 0.32

3.73 ± 0.35 ¥

4.08 ± 0.32

4.59 ± 0.35

All values were expressed as mean ± standard error where n=10, unless otherwise specified. Different letters on
each row indicated a significant difference at p ≤ 0.05.

†
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n=8; ¥n=9.

Table 5.4. Effects of the purified Chinese sweet leaf tea (Rubus suavissimus) extract (GER) and
green tea (Camellia sinensis) powder (GTP) on the serum chemistry values of diet-induced obese
rats compared to the control groups receiving high fat (HFD) and normal diet (STD),
respectively.
Groups

HFD

STD

GER

GTP

Glucose (mg/dL)

196.80 ± 13.36

216.10 ± 13.90

206.89 ± 16.31¥

172.50 ± 10.89†

AST(IU/L)

142.78 ± 16.08¥

194.89 ± 41.82¥

206.44 ± 32.64

168.57 ± 28.48*

ALT(IU/L)

39.44 ± 2.14¥

51.86 ± 3.84*

45.22 ± 4.98

48.57 ± 2.83*

AP (IU/L)

267.70 ± 15.35a

227.90 ± 7.94ab

205.40 ± 9.31b

217.20 ± 10.83b

CK (IU/L)

3785.33 ± 1399

2847.50 ± 1295¥

5792.44 ± 2149¥

4820.63 ± 1806†

Bilirubin (mg/dL)

0.19 ± 0.04

0.22 ± 0.04

0.36 ± 0.05

0.25 ± 0.05

Protein (g/dL)

5.91 ± 0.08

5.76 ± 0.12

5.98 ± 0.12

5.80 ± 0.10

Albumin (g/dL)

3.12 ± 0.07

3.12 ± 0.07

3.31 ± 0.07

3.24 ± 0.06

Globulin (g/dL)

2.79 ± 0.06

2.64 ± 0.06

2.67 ± 0.06

2.56 ± 0.06

Cholesterol (mg/dL)

103.50 ± 3.20†a

61.80 ± 3.30c

79.90 ± 4.72b

84.80 ± 4.05b

BUN (mg/dL)

17.50 ± 0.48ab

19.10 ± 0.43a

16.40 ± 0.64bc

14.40 ± 0.60c

Creatinine (mg/dL)

0.30 ± 0.00b

0.31 ± 0.01b

0.33 ± 0.02ab

0.38 ± 0.02a

Calcium (mg/dL)

10.34 ± 0.15

10.26 ± 0.19

10.02 ± 0.24

9.93 ± 0.19

Phosphorus (mg/dL)

7.35 ± 0.22

8.00 ± 0.50

8.18 ± 0.60

8.45 ± 0.76

Sodium (mmol/L)

141.40 ± 0.48

141.30 ± 0.75

140.70 ± 0.96

140.60 ± 0.67

Potassium (mmol/L)

6.35 ± 0.24

6.51 ± 0.39

7.39 ± 0.63¥

6.55 ± 0.42†

Chloride (mmol/L)

100.30 ± 0.47

99.90 ± 0.64

101.00 ± 0.58

100.20 ± 0.59

Bicarbonate(mmol/L)

23.82 ± 0.45

24.28 ± 0.64

22.48 ± 0.86

22.36 ± 0.96

Anion Gap (mmol/L)

23.63 ± 0.70

23.63 ± 0.91

25.13 ± 1.31

25.77 ± 1.55

All values were expressed as mean ± standard error where n=10, unless otherwise specified. Different letters on
each row indicated a significant difference at p ≤ 0.05. *n=7;
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†

n=8; ¥n=9.

5.4 Discussion
Chinese sweet leaf tea is a popular beverage leaf tea due to its natural sweet taste. In southern
China, it has long been used as a traditional folk remedy. This folk medicine has been put under
scientific investigation in recent years. Liu et al. (2006) reported that the anti-angiogenic
properties of the Chinese sweet leaf tea extract are partially exerted by the presence of gallic
acid. Chou et al. (2009) revealed five bioactive markers, gallic acid, rutin, ellagic acid,
rubusoside, and steviol monoside in the leaf. However, preliminary studies demonstrated that
only gallic acid, ellagic acid, and rubusoside were absorbed in vivo. Previously, our study found
that the standardized Chinese sweet leaf tea extract at a 0.5g/kg dose caused a 6.7% cumulative
weight loss in normal rodents (non-obesity-prone) against the control group. More surprisingly,
the use of a combination of the three major marker compounds (i.e., gallic acid, ellagic acid, and
rubusoside) had the same anti-obesity effect as the use of the whole crude extract itself. Those
results indicate that gallic acid, ellagic acid, and rubusoside represent the majority, if not all, of
the responsible components in the Chinese sweet leaf tea extract that causes significant weight
loss through unknown mechanisms.
Although the mechanisms of action are unknown, it is suspected that the observed antiobesity effect is likely caused by multiple components with possible synergistic interactions at
multiple sites of actions. For example, gallic acid has been reported to be an inhibitor of alphaglucosidase, which may further reduce the breakdown of carbohydrates to simple sugars such as
glucose and fructose (Li et al., 2007). Hsu et al. (2007) also reported the anti-obesity effect after
the administration of gallic acid at the dose of 100 mg/kg of body weight. Ellagic acid, indeed,
may be partially responsible in the anti-obesity effect in mice after the administration of
pomegranate leaf extract containing 10.6% w/w of ellagic acid (Lei et al., 2007). Rubusoside has
shown some anti-bacterial activity (unpublished data) and could contribute to the digestion of
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energy in the colon. Gallic acid could play a role systematically as an angiogenesis inhibitor and
could cause reduced blood vessel formation and growth in the adipose tissues, thus leading to a
reduced fat accumulation. These possible multiple mechanisms of action, multiple action sites,
and synergism of different bioactive components warrant further investigations. Regardless, it is
safe to conclude that the current results verified the hypothesis that the anti-obesity effect of the
Chinese sweet leaf tea extract is due to the combination of gallic acid, ellagic acid, and
rubusoside. It is clear that GER could be used to replace the standardized whole extract to
produce the same anti-obesity effects.
This is the first report on the anti-obesity effect of the purified sweet leaf tea extract on
obese-prone SD rats. Our present study clearly demonstrated that the combination of gallic acid,
ellagic acid, and rubusoside (GER), in a similar composition to the standardized Chinese sweet
leaf tea extract at a dosage of 0.8 g/kg of body weight (0.08% w/w), reduced significantly the
body weight gain of the diet-induced obese rats by 22% and the total abdominal fat accumulation
by 48%. Since abdominal fat accounts for the majority of weight gain in obese phenotypes, it is
reasonable to state that the pronounced weight loss was in fact fat loss. One of the most
interesting results was that the same anti-obesity effects produced by two drastically different
methods. The first method put obesity-prone rats on high-fat diet (i.e., 60% of the total calories
from fat) that was supplemented with GER. The other method put obesity-prone rats on standard
low-fat diet (i.e., 14% of the total calories from fat) alone without any GER. Both methods
caused approximately 22% less body weight gain. In addition, the total cholesterol in the GER
group was significantly lower than the control group. This shows that GER has the ability to
suppress body weight gain and improve lipid profiles when a fatty diet is consumed. Whether the
same effects produced by GER on high-fat diet-fed rat are mechanistically similar to those
produced in GER-free standard (low-fat) diet-fed rat, is subjected to further investigation.
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However, it raises a very interesting question on how the extra fat in the diet is counter-balanced
by the use of GER. Since the food intake was not affected in the GER group, it is imperative to
predict that the administration of GER might have actually suppressed the energy absorption in
the gastrointestinal tract during the treatment period. In addition to the observed anti-obesity
effect, the blood glucose level was significantly improved after 4 weeks of extract administration
and showed a trend of improvement after 8 weeks of treatment. This represents a new piece of
scientific evidence to support the use of Chinese sweet leaf tea as a potential remedy to treat
diabetes (Huang and Jiang, 2002). Obesity and insulin resistance are interrelated. Whether the
anti-obesity effect of GER serves as a cause of the improvement of blood glucose levels is not
understood.
Botanical extracts have been good sources of anti-obesity natural ingredients. One of the
most extensively studied medicinal plants is probably the green tea. Green tea is a non-fermented
tea possessing various health benefits. Currently, there are numerous reports on green tea and its
anti-obesity effects by inhibiting the lipogenesis process (Dulloo et al., 1999; Hasegawa et al.,
2003; Zheng et al., 2004; Wolfram et al., 2006; Kim et al., 2009; Nagao et al., 2009) and by
increasing thermogenesis (Kovacs et al., 2004; Thielecke and Boschmann, 2009). With strong
literature support, green tea extract was chosen in our study as a positive control. The use of
green tea provides a benchmark to assess the effect of GER on the obesity-prone rats. Among the
components found in the green tea, EGCG, which represents approximately 59% of the total
catechins, and caffeine were likely to cause the effect of weight reduction. Zheng et al. (2004)
reported that the administration of caffeine and catechins resulted in similar effects of weight
reduction as the green tea extract by reducing the weight of intraperitoneal adipose tissues by
23%. The body weight reduction was even greater than those receiving caffeine, catechins, or
theanine alone. Studies have argued that the anti-obesity effect of green tea was mainly due to
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the presence of caffeine since its intake has been known to increase thermogenesis and fat
oxidation (Cabrera et al., 2006; Thielecke and Boschmann, 2009). Dulloo et al. (1999) also
suggested that although caffeine may not be effective alone, it may trigger the synergistic
reaction with other compounds in the green tea extract, thereby inducing the thermogenesis and
fat oxidation in obese subjects. This hypothesis was further supported by Zheng et al. (2004).
Our results confirmed the findings by others and showed an effective weight reduction in the
obese-prone SD rats after an administration of green tea extract containing 16.5% of EGCG and
8.97% of caffeine at a dosage of approximately 1g/kg of body weight. The weight difference
reached 32% at the end of the 9-week treatment period compared to the high-fat diet control
group. The difference was even 10% higher than those receiving a slightly lower dose of sweet
leaf tea extract equivalent GER. Despite the beneficial anti-obesity effect, caffeine has been
known to increase the risk of coronary heart disease, diabetes, blood pressure, and mental
alertness (Geleijnse 2008; Kennedy et al., 2008; Van Dam 2008) and may not be a good
candidate for weight loss treatment. The toxicity issues related to caffeine and ephedrine
consumption as a weight loss supplementation casted additional doubt on the use of caffeine as a
safe weight loss agent (Haller et al., 2002; Dunnick et al., 2007). Although animal studies,
including the current study, support the use of green tea as a weight management agent, human
studies have found that the anti-obesity effect of green tea fell short of expectations (Kao et al.,
2006; Wolfram et al., 2006; Hsu et al., 2008). Kao et al., (2006) reported that the controversial
results from the green tea may possibly be due to the purity of extract used, experimental
designs, the period of administration, physiological status of the subjects, as well as caffeine
content in the green tea. In addition, based on daily observations, the GTP group was physically
more active than all other groups. The caffeine administration in the present study, which was
equivalent to the daily consumption of an average weight person (70 kg) of almost 35 cups of
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green tea with an average caffeine content at 25 mg per cup, was way beyond the daily caffeine
consumption of a normal healthy human (i.e., 50 mg daily). This may increase the possibility of
side effects. Although the effect of green tea on weight suppression was shown to be effective,
the long-term effects on human health, resulting from caffeine consumption, especially at high
doses, are still unknown.
The qualitative fingerprints of the GER and the standardized Chinese sweet leaf tea
extract (RUS) showed the existence of the three major components without the presence of
EGCG or caffeine, which differentiate the Chinese sweet leaf tea from the green tea. Blood
chemistry and hematological results showed no sign of toxicity of GER after a 9-week
administration. Although the anti-obesity effect was stronger in the GTP group than in the GER,
there are some major advantages of the latter. First, the habitual caffeine intake from the GTP
may affect human health in the long term. In contrast, GER does not contain caffeine and thus
has no predicted side effects. Second, the effective GER dose was 0.22g/kg of body weight
(equivalent to the standardized extract dose of 0.8g/kg of body weight) comparing to the GTP at
1g/kg of body weight. Third, the GER can be better controlled with a fixed concentration of
known compounds than the GTP or whole sweet leaf tea extract with hundreds of compounds.
Thus, GER, in the same fashion as the combinational drug formulations, could avoid the
common challenge of batch-to-batch variations associated with extract preparations. In addition,
by removing almost 70% of inactive components from the crude extract, the palatability of GER
has increased to levels for medicinal food or botanical drug development. Fourth, since the
effect of GER was almost comparable to the STD group, it can be used by people who have
difficulty in changing to a healthier diet and lifestyle towards better.
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5.5 Summary
The current study revealed the anti-obesity effect of the purified Chinese sweet leaf tea extract
(GER) on obese-prone rodents after the administration of extract, at an equivalent standardized
extract dose of 0.8g/kg of body weight, for 9 weeks. The weight reduction reached 22% when
compared to the high-fat diet group with 48% weight loss attributed by total abdominal fat loss.
Green tea demonstrated an even stronger anti-obesity effect at 32% less weight gain than the
high-fat diet control group but with higher a dose at 1g/kg of body weight. However, the adverse
effects resulting from habitual caffeine intake from green tea are persistent and controversial
results from clinical studies have shown that the anti-obesity effect of green tea is questionable.
Instead, GER, without the presence of caffeine, is safe to consume with controlled quality as
shown in current study. Moreover, the effective dose of GER was almost 5-fold lower than the
green tea extract. With a similar effect as in the low-fat diet group, GER counter-balanced the
effect of the high fat diet. Although the mechanisms remain unknown, they may involve multiple
pathways or targets. Nevertheless, the current study raises a possibility that GER may be an
alternative health supplement in treating obesity and that the mechanisms may be different than
in GTP.
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CHAPTER 6. CONCLUSIONS AND FUTURE RESEARCH
Current study discovered a new direction of the application of Chinese sweet leaf tea
beyond its historical use as a beverage leaf tea or natural sweetener. Based on all preliminary and
final results, we concluded that:
1.

Based on the sweetness of extract, the traditional hot water extraction was satisfactory in
extracting rubusoside considering the unnecessary use of ethanol. However, sequential
extraction method is warranted to produce a new sweet leaf tea extract with maximized
levels of all marker compounds.

2. Alcohol precipitation could be a simple purification tool to remove the polysaccharide
from the water extract of Chinese sweet leaf tea.
3. The Chinese sweet leaf tea extract could be a useful functional ingredient in suppressing
the weight gain of obese individual where gallic acid, ellagic acid, and rubusoside may be
the three major compounds responsible for the anti-obesity effect. Because there were no
difference in food intake, we believed that the 22% weight loss in obese animal model
may possibly due to the decreased of fat accumulation either caused by increased in
energy expenditure or decreased in energy absorption.
Future research will be focused on the mechanistic investigations of the Chinese sweet
leaf tea or its purified extract on the suppression of fat accumulation.
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APPENDIX A. DIET COMPOSITIONS
Purified AIN-93G Liquid Rodent Diet (Use at 263.194g/L of cold water)
Calories (%) Provided by the Major Nutrients
Nutrient
Carbohydrates
Proteins
Fat

Calories (%)
64.0
19.3
16.7

Major Ingredients in the Liquid Diet
Ingredient
Casein
Sucrose
Cellulose
Maltose Dextrin
Soybean Oil
t-Butylhydroquinone (TBHQ)
Mineral Mix (See table below for details)
Vitamin Mix (See table below for details)
L-Cystein
Choline Butartrate
Xanthan Gum

grams/Liter of Diet
53.00
26.50
13.30
135.40
18.6
0.004
9.28
2.65
0.8
0.66
3.0

AIN-93G Mineral Mix for Liquid Diet (Use at 9.28g/L of Diet)
Ingredient
Calcium Carbonate
Potassium Phosphate, monobasic
Potassium Citrate H2O
Sodium Chloride
Potassium Sulfate
Magnesium Oxide
Ferrous Sulfate 7H2O
Zinc Carbonate
Manganous Carbonate
Cupric Carbonate
Potassium Iodate
Sodium Selenate
Ammonium Paramolybdate 4H2O
Sodium Metasilicate 9H2O
Chromium Potassium Sulfate 12H2O

grams/kilogram
357.00
196.00
70.78
74.00
46.60
24.00
5.21
1.65
0.63
0.30
0.01
0.01025
0.00795
1.45
0.275
97

Lithium Chloride
Boric Acid
Sodium Fluoride
Nickel Carbonate
Ammonium Vanadate
Sucrose, finely powdered

0.0174
0.0815
0.0635
0.0318
0.0066
221.876

AIN-93VX Vitamin Mixture for Liquid Diet (Use at 10g/kg Diet)
Ingredient
Niacin
Calcium Pantothenate
Pyridoxine HCl
Thiamine HCl
Riboflavin
Folic acid
Biotin
Vitamin E Acetate (500 IU/g)
Vitamin B12 (0.1%)
Vitamin A Palmitate (500,000 IU/g)
Vitamin D3 (400,000 IU/g)
Vitamin K1/Dextrose Mix (10 mg/g)
Sucrose

grams/kilogram
3.00
1.60
0.70
0.60
0.60
0.20
0.02
15.00
2.50
0.80
0.25
7.50
967.23

Standard Chow Diet (Diet # 5001) Ingredients (Provided by Laboratory Rodent Diet)
Calories (%) Provided by the Major Nutrients
Nutrient
Carbohydrate
Protein
Fat

Calories (%)
57.99
28.51
13.49

Nutrients Composition in the Standard Chow Diet
Nutrients
Total Protein
Arginine
Cystine
Glycine
Histidine
Isoleucine
Leucine
Lysine

23.9 %
1.41 %
0.31 %
1.21 %
0.57 %
1.14 %
1.83 %
1.41 %
98

Methionine
Phenylalanine
Tyrosine
Threonine
Tryptophan
Valine
Serine
Aspartic Acid
Glutamic Acid
Alanine
Proline
Taurine
Fat (ether extract)
Fat (acid hydrolysis)
Cholesterol
Linoleic Acid
Linolenic Acid
Arachidonic Acid
Omega-3 Fatty Acids
Total Saturated Fatty Acids
Total Monounsaturated Fatty Acids
Crude Fiber
Starch
Glucose
Fructose
Sucrose
Lactose

0.67 %
1.04 %
0.71 %
0.91 %
0.29 %
1.17 %
1.19 %
2.81 %
4.37 %
1.43 %
1.49 %
0.02 %
5.00 %
5.70 %
200 ppm
1.22 %
0.10 %
<0.01 %
0.19 %
1.56 %
1.60 %
5.10 %
31.90 %
0.22 %
0.30 %
3.70 %
2.01 %

Minerals Composition in the Standard Chow Diet
Mineral
Ash
Calcium
Phosphorus
Phosphorus (non-phytate)
Potassium
Magnesium
Sulfur
Sodium
Chlorine
Fluorine
Iron
Zinc
Manganese
Copper
Cobalt

7.00 %
0.95 %
0.66 %
0.39 %
1.18 %
0.21 %
0.36 %
0.40 %
0.67 %
16 ppm
270 ppm
79 ppm
70 ppm
13 ppm
0.90 ppm
99

1.00 ppm
1.20 ppm
0.30 ppm

Iodine
Chromium
Selenium

Vitamins Composition in the Standard Chow Diet
Vitamin
Carotene
Vitamin K
Thiamin Hydrochloride
Riboflavin
Niacin
Pantothenic Acid
Choline Chloride
Folic Acid
Pyridoxine
Biotin
Vitamin B12
Vitamin A
Vitamin D3 (added)
Vitamin E
Ascorbic Acid

2.30 ppm
1.30 ppm
16 ppm
4.5 ppm
120 ppm
24 ppm
2250 ppm
7.1 ppm
6.0 ppm
0.30 ppm
50 mcg/kg
15 IU/g
4.5 IU/g
42 IU/kg
--

High Fat Diet (Provided by Research Diet, Inc. Product # D12492)
Calories (%) Provided by the Major Nutrients
Nutrient
Carbohydrate
Protein
Fat

Calories (%)
20.00
20.00
60.00

Major Ingredients in the High Fat Diet
Ingredient
Casein, 80 Mesh
L-Cystein
Corn Starch
Maltodextrin 10
Sucrose
Cellulose, BW200
Soybean Oil
Lard
Mineral Mix S10026

grams/100 grams
200
3
0
125
68.8
50
25
245
10
100

DiCalcium Phosphate
Calcium Carbonate
Potassium Citrate, 1 H2O
Vitamin Mix V10001
Choline Bitartrate
FD&C Blue Dye

13
5.5
16.5
10
2
0.05
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APPENDIX B. SAS PROGRAMS FOR STATISTICAL ANALYSES
SAS Programs for the analyses of the effects of methods and solvent systems on the chemical
components of the Chinese sweet leaf tea extract
dm 'log;clear;output;clear';
options nodate nocenter pageno=1;
PROC IMPORT OUT= WORK.extraction
DATAFILE= "F:\Lab\Crude Extraction\Data\Extraction data.xls"
DBMS=EXCEL REPLACE;
SHEET="SAS";
GETNAMES=YES;
MIXED=NO;
SCANTEXT=YES;
USEDATE=YES;
SCANTIME=YES;
RUN;
Data extraction;
set WORK.extraction;
run;
Title1'Crude Extraction';
PROC PRINT data=extraction;
run;
PROC Mixed;
Title2'GA Yield;
Classes Method Solvent;
Model GA = Method Solvent Method*Solvent;
LSMEANS Method Solvent Method*Solvent/Adjust=Tukey;
run;
PROC Mixed;
Title2'RUT Yield;
Classes Method Solvent;
Model RUT = Method Solvent Method*Solvent;
LSMEANS Method Solvent Method*Solvent/Adjust=Tukey;
run;
PROC Mixed;
Title2'EGA Yield;
Classes Method Solvent;
Model EGA = Method Solvent Method*Solvent;
LSMEANS Method Solvent Method*Solvent/Adjust=Tukey;
run;
PROC Mixed;
Title2'RUB Yield;
Classes Method Solvent;
Model RUB = Method Solvent Method*Solvent;
LSMEANS Method Solvent Method*Solvent/Adjust=Tukey;
run;
PROC Mixed;
Title2'STM Yield;
Classes Method Solvent;
Model STM = Method Solvent Method*Solvent;
LSMEANS Method Solvent Method*Solvent/Adjust=Tukey;
run;Quit;
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SAS Programs for the Regression Analyses of the Supernatant, Precipitant, Polysaccharides, and
Chemical Components Resulted from Alcohol Precipitation
dm 'log;clear;output;clear';
Title1 'Alcohol Precipitation';
options nodate nocenter pageno=1;
PROC IMPORT OUT= WORK.AP
DATAFILE= "F:\ALcohol Precipitation_07\EtOH_prep_chart.xls"
DBMS=EXCEL REPLACE;
SHEET="SAS_YieldPSAC";
GETNAMES=YES;
MIXED=NO;
SCANTEXT=YES;
USEDATE=YES;
SCANTIME=YES;
RUN;
data AP_reg;
set WORK.AP;
RUN;
ODS RTF File = 'F:\AP_Regression Analysis_YieldPSAC';
PROC GLM data=AP_reg;
Title2 'Regression Analysis_Precipitant and Supernatant Yield;
model Ppercent Spercent= treatment treatment*treatment;
output out=AP r=resid_Ppercent resid_Spercent p=p_Ppercent p_Spercent;
run;
PROC GLM data=AP_reg;
Title2 'Regression Analysis_PSAC';
model PSAC= treatment treatment*treatment;
output out=AP r=resid_PSAC p= p_PSAC;
run;
PROC Sort data=AP_reg;
by treatment;
run;
PROC MEANS data=AP_reg mean std stderr n noprint;
Title2 'PROC MEAN';
by treatment;
var Spercent Ppercent PSAC;
output out=ap30 mean=m_Spercent m_Ppercent m_PSAC std=s_Spercent s_Ppercent
s_PSAC stderr=se_Spercent se_Ppercent se_PSAC;
run;
PROC PRINT data=ap30;
run;
PROC Univariate data=AP normal plot;
Title2 'PROC UNIVARIATE';
Var resid_Ppercent resid_Spercent resid_PSAC; run;
ODS RTF CLOSE;Quit;
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PROC GLM data=AP_reg;
Title2 'Regression Analysis of the Chemical Components';
Model GA EGA RUB SM=treatment treatment*treatment;
Output out=AP_1 r= resid_GA resid_EGA resid_RUB resid_SM p=p_GA p_EGA p_RUB
p_SM;run;
PROC REG data=AP_reg;
Title2 'Regression Analysis RUT';
Model RUT =treatment;
output out=AP_2 r=resid_RUT p=p_RUT;run;
PROC SORT data=AP_reg;
by treatment;run;
PROC MEANS data=AP_reg mean std stderr n noprint;
by treatment;
var GA RUT EGA RUB SM ;
output out=ap30 mean=m_GA m_RUT m_EGA m_RUB m_SM std= s_GA s_RUT s_EGA
s_RUB s_SM stderr=se_GA se_RUT se_EGA se_RUB se_SM;run;
PROC PRINT data=ap30;run;
PROC Univariate data=AP_1 normal plot;
Var resid_GA resid_EGA resid_RUB resid_SM;run;
PROC Univariate data=AP_2 normal plot;
Var resid_RUT;run;
ODS RTF CLOSE;QUIT;

SAS Programs for the Regression Analyses of the Response of Chemical Components to the
dosage levels
dm 'log;clear;output;clear';
Title1 'Animal Study_Absorption';
options nodate nocenter pageno=1;
PROC IMPORT OUT= WORK.AP
DATAFILE= "G:\Lab\Animal Study\Absorption
Study_Summer08\XRUS0505\Data\Absorption studyLFTrial_XRUS_20080421_dose
response.xls"
DBMS=EXCEL REPLACE;
SHEET="SAS";
GETNAMES=YES;
MIXED=NO;
SCANTEXT=YES;
USEDATE=YES;
SCANTIME=YES;
RUN;
data Dose;
set WORK.AP;RUN;
PROC GLM data=Dose;
Title2 'Dose Response’;
model GA EGA RUB = Dose Dose*Dose;
Output out=response r=resid_GA resid_EGA resid_RUB;run;
Proc Univariate data=Dose normal plot;
var response;
run;
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SAS Programs for the Analyses of the RUS and GER on the Body Weight Changes and Relative
Daily Food Intake on Normal SD rats
dm 'log;clear;output;clear';
options nodate nocenter pageno=1;
PROC IMPORT OUT= WORK.Wtloss
DATAFILE= "G:\Lab\Animal
Study\Rubus_WtLossSummer08\WtLoss_Rubus20080610\Data\Rubus_20080610.xls"
DBMS=EXCEL REPLACE;
SHEET="WtGain_SAS";
GETNAMES=YES;
MIXED=NO;
SCANTEXT=YES;
USEDATE=YES;
SCANTIME=YES;
RUN;
Data Weight (Drop=WDay7 WDay15 WDay21 WDay29 WDay35 WDay43 WDay49 WDay55
WDay61 WDay70 WDay74);
set Wtloss;
array W[11] WDay7 WDay15 WDay21 WDay29 WDay35 WDay43 WDay49 WDay55 WDay61
WDay70 WDay74;
do day= 1 to 11;
**1=Day7 2=Day 15 3=Day21 4=Day29 5=Day35 6=Day43 7=Day49 8=Day55 9=Day61
10=day70 11=day74;
Wt= W[Day];
output;end;run;
Proc Print data=weight;run;
PROC mixed data=weight;
Title2 'Body Weight Changes_Normalrat’;
Class Rat Treatment day;
model Wt = treatment day treatment*day/ influence ddfm=Satterthwaite
outp=ResidWt;
repeated day/ type=ar(1) subject=rat(treatment);
LSMEANS treatment day treatment*day/ Adjust=Tukey;
Run;
PROC mixed data=weight;
Title2 'Relative Daily Food Intake_normal rat’;
Class Rat Treatment day;
model FoodIntake = treatment day treatment*day/ influence
ddfm=Satterthwaite outp=ResidWt;
repeated day/ type=ar(1) subject=rat(treatment);
LSMEANS treatment day treatment*day/ Adjust=Tukey;
Run;
Proc Univariate data=ResidWt PLOT NORMAL;
Var Resid;
run;
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SAS Programs for the Analyses of the Hematology and Blood Chemistry of the Normal SD rats
after 10-week Administration of Extracts
dm 'log;clear;output;clear';
options nodate nocenter pageno=1;
PROC IMPORT OUT= WORK.Wtloss
DATAFILE="H:\Lab\Animal Study_08\Weight
Loss\WtLoss_Rubus20080610\SAS.xls"
DBMS=EXCEL REPLACE;
SHEET="SAS_Blood";
GETNAMES=YES;
MIXED=NO;
SCANTEXT=YES;
USEDATE=YES;
SCANTIME=YES;
RUN;
DATA Blood;
set Wtloss;
PROC GLM data=Blood;
Title2 'Hematology Test_Normal Rat';
Class group;
Model RBC HEM HET RDW MCV MCH MCHC PLA MPV WBC = group /influence Output
out=resid; LSMEANS group/ adjust= tukey; Run;
PROC UNIVARIATE data=resid PLOT NORMAL; Var resid;
run;
PROC GLM data=Blood;
Title2 'Blood Chemistry_Normal Rat';
Class group;
Model Glu ALT AST AP BUN CRE = group /influence Output out=resid; LSMEANS
group/ adjust= tukey; Run;
PROC UNIVARIATE data=resid PLOT NORMAL;
Var resid;
run;

SAS Programs for the Analyses of the Effects of GER and GTP on the Body Weight Changes
and Relative Daily Food Intake in Diet-Induced Obese SD Rats
dm 'log;clear;output;clear';
options nodate nocenter pageno=1;
PROC IMPORT OUT= WORK.Wtloss
DATAFILE= "G:\Lab\Animal Study\RUS_Wt
Loss_09\RUS_Data20090428.xls"
DBMS=EXCEL REPLACE;
SHEET="Wt_SAS";
GETNAMES=YES;
MIXED=NO;
SCANTEXT=YES;
USEDATE=YES;
SCANTIME=YES;
RUN;
DATA Wt;
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set Wtloss;
array W[13] WDay1 WDay2 WDay3 WDay4 WDay5 WDay6 WDay7 WDay8 WDay9 WDay10
WDay11 WDay12 WDay13;
do day = 1 to 13;
Wt = W[Day];
**1=wk0-1 2=wk0-2 3=wk0-3 4=wk0-4 5=wk1 6=wk2 7=wk3 8=wk4 9=wk5 10=wk6 11=wk7
12=wk8 13=wk9;
output;end;run;
PROC Mixed data=Wt;
Class Group Day;
Title2 'Body Weight Changes_Obese Rat';
Model Wt = Group Day Group*Day / ddfm=Satterthwaite outp=ResidWt;
repeated Day/ type=ar(1) subject=rat(Group);
LSMEANS Group day Group*day/ Adjust=Tukey;
run;
PROC Mixed data=Wt;
Class Group Day;
Title2 'Relative Daily Food Intake_Obese Rat';
Model FoodIntake = Group Day Group*Day / ddfm=Satterthwaite outp=ResidWt;
repeated Day/ type=ar(1) subject=rat(Group);
LSMEANS Group day Group*day/ Adjust=Tukey;
run;
PROC UNIVARIATE data=ResidWt PLOT NORMAL;
Var Resid;run;

SAS Programs for the Analyses of the Effects of GER and GTP on the Weight of Organs and
Tissues
dm 'log;clear;output;clear';
options nodate nocenter pageno=1;
PROC IMPORT OUT= WORK.Wtloss
DATAFILE= "G:\Lab\Animal Study\RUS_Wt
Loss_09\RUS_Data20090428.xls"
DBMS=EXCEL REPLACE;
SHEET="SAS_Organs_Contents";
GETNAMES=YES;
MIXED=NO;
SCANTEXT=YES;
USEDATE=YES;
SCANTIME=YES;
RUN;
DATA Organs;
set Wtloss;
Proc Print Data=Organs;
run;
PROC Mixed data=Organs;
Class Group;
Model Cecum = Group / ddfm=Satterthwaite outp=ResidWt;
LSMEANS Group / Adjust=Tukey;
run;
PROC UNIVARIATE data=ResidWt PLOT NORMAL;
Var Resid;
run;
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SAS Programs for the Analyses of the Effects of GER and GTP on the Weight of Organs and
Tissues
dm 'log;clear;output;clear';
options nodate nocenter pageno=1;
PROC IMPORT OUT= WORK.Wtloss
DATAFILE= "G:\Lab\Animal Study\RUS_Wt
Loss_09\RUS_Data20090428.xls"
DBMS=EXCEL REPLACE;
SHEET="BG_SAS";
GETNAMES=YES;
MIXED=NO;
SCANTEXT=YES;
USEDATE=YES;
SCANTIME=YES;
RUN;
DATA BG;
set Wtloss;
array W[3] WDay1 Wday2 Wday3;
do day = 1 to 3;
BG = W[Day];
**1 = Wk0 2=Wk4 3=Wk8;
output;
end;
run;
Proc Print Data=BG;
run;
PROC Mixed data=BG;
Class Group Day;
Model BG = Group Day Group*Day / ddfm=Satterthwaite outp=ResidWt;
repeated Day/ type=ar(1) subject=rat(Group);
LSMEANS Group day Group*day/ Adjust=Tukey;
run;
PROC UNIVARIATE data=ResidWt PLOT NORMAL;
Var Resid;run;
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SAS Programs for the Analyses of the Hematology and Blood Chemistry of the Diet-induced
Obese Rats after 9-week Administration of Extracts
dm 'log;clear;output;clear';
options nodate nocenter pageno=1;
PROC IMPORT OUT= WORK.Wtloss
DATAFILE= "G:\Lab\Animal Study\RUS_Wt
Loss_09\RUS_Data20090428.xls"
DBMS=EXCEL REPLACE;
SHEET="Blood_SAS";
GETNAMES=YES;
MIXED=NO;
SCANTEXT=YES;
USEDATE=YES;
SCANTIME=YES;
RUN;
DATA Chem;
set Wtloss;
Proc Print Data=Chem;
run;
PROC GLM data=Chem;
Class Group;
Model RBC HMG HMT RDW MCV MCH MCHC PLA MPV WBC = Group /
ddfm=Satterthwaite outp=ResidWt influence;
LSMEANS Group / Adjust=Tukey;
run;
PROC GLM data=Chem;
Class Group;
Model GLU AST ALT AP CK BIL PRO ALB GLO CHO BUN CRE CAL PHOS SOD POT CHL
BIC ANION = Group / ddfm=Satterthwaite outp=ResidWt influence;
LSMEANS Group / Adjust=Tukey;
run;

PROC UNIVARIATE data=ResidWt PLOT NORMAL;
Var Resid;
run;
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APPENDIX D. ABBREVIATIONS
ALT: Alanine Aminotransferase
ANOVA: Analysis of Variance
AP: Alcohol Precipitation
APH: Alkanine Phosphatase
AST: Aspartate Aminotransferase
BUN: Blood Urea Nitrogen
CK: Creatinine Kinase
CV: Coefficient of Variation
EGA: Ellagic Acid
EtOH: Ethanol
GA: Gallic Acid
GER: Gallic acid, Ellagic acid, and Rubusoside; Purified Chinese Sweet Leaf Tea Extract
GI: Gastrointestinal
GTP: Green Tea Powder
HP: High-Pressurized Liquid Extraction
HPLC: High Performance Liquid Chromatography
HW: Hot Water Extraction
LP: Low-Pressurized Liquid Extraction
MA: Maceration
MCH: Mean Corpuscular Hemoglobin
MCHC: Mean Corpuscular Hemoglobin Concentration
MCV: Mean Corpuscular Volume
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PLE: Pressurized Liquid Extraction
PSAC: Polysaccharides
RBC: Red Blood Cell
RDW: Red Blood Cell Distribution Width
RUB: Rubusoside
RUS: Standardized Leaves Extract of Rubus suavissimus
RUT: Rutin
SD: Sprague-Dawley Rat
STM: Steviol Monoside
WBC: White Blood Cell
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